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Abstract 
Sox proteins are a family of transcription factors characterised by the 
presence of a conserved HMG box domain that mediates their binding to 
DNA. Ten groups of Sox proteins have been identified on the basis of their 
sequence similarities and named A-J. In particular, the SoxB1 subgroup is 
composed by highly conserved transcription factors that are involved in 
the differentiation of the cells towards a neural fate and the specification 
of neural tissue. During the embryonic development of several vertebrate 
species the first of the SoxB1 proteins to be expressed is Sox3, which is 
known to act both as a transcriptional activator and a transcriptional 
repressor at different stages of development. At the present time, little is 
known about the regulation of the balance between these two functions. 
Therefore, this study was aimed to identify the regions of Sox3 that are 
involved in its functioning as a repressor or as an activator. In order to 
meet this aim a deletion mutagenesis approach was developed to 
investigate how the deletion of different regions of Sox3 would have 
changed the protein’s function. A specific cloning strategy was designed in 
order to obtain twelve Sox3 deletion mutants, each carrying a deletion of 
about 20 amino acids, so that the regions deleted covered most of the 
protein sequence. The effects caused by the over-expression of each 
deletion mutant were then tested on zebrafish embryos and compared to 
the effects of over-expression of the wild type Sox3. Western blot analysis 
confirmed that microinjection of all the mutants into 1- 4 cell stage 
embryos, as well as microinjection of wild type sox3, resulted in similar 
levels of protein expression at sphere stage. The embryos microinjected 
with sox3 deletion mutants showed different phenotypes at 24 hours post 
fertilization (hpf), confirming that they affected the functioning of the 
protein differentially. In order to investigate deeper these functional 
changes, microinjected embryos were analysed at earlier stage of 
development. In zebrafish, Sox3 acts as a repressor of the organizer 
formation at sphere stage.  Analysis of the effects of over-expression of 
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Sox3 deleted mutants on the expression of the organizer marker genes 
bozozok and goosecoid, and the comparison with the effects caused by the 
over-expression of wild type Sox3, led to the identification of protein 
regions involved in Sox3 transcriptional repressor function. Analysis of the 
ability of Sox3 deletion mutants to induce the transcription of a luciferase 
reporter gene, compared to the wild type Sox3, allowed the identification 
of regions of Sox3 involved with its transcriptional activator function. The 
data obtained allowed us to draw a presumptive functional map of Sox3. 
The consistency of this map with evidence found in the literature led to the 
formulation of different hypotheses that would explain the functions 
associated with the regions identified. These promising data provide a 
basis for future studies, which will be aimed to the validation of the 
hypothesis formulated and to the identification of the amino acid residues 
that are responsible for the functions mediated by the regions identified.  
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1. Introduction 
1.1. The Zebrafish (Danio rerio) 
The Zebrafish (scientific name Danio rerio, Fig. 1.1) is a bony fish whose 
natural habitats are the tropical fresh water rivers of northern India, 
northern Pakistan, Nepal, and Bhutan. Because of its small size and ease of 
culture, it has become one of the embryologists’ favourite and most used 
model organisms for the study of vertebrate development. 
 
1.1.1. History and Advantages of the use of Zebrafish as 
a Model Organism 
Zebrafish has been largely used as model organism since George 
Streisinger, a scientist of the University of Oregon, started using it in the 
1970s.  The reasons why Streisinger, who was also a fish hobbyist, started 
working with the zebrafish at the University of Oregon was that it was a 
simpler model than the mouse and easier to manipulate genetically 
(Streisinger et al. 1981). Moreover, the zebrafish is easy to breed and 
maintain, and it is small enough to easily house large numbers, but also 
large enough to allow experimental manipulations. Another useful 
Figure 1.1 The Zebrafish (Credit: ScienceDaily®). 
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characteristic of this fish is the rapid development: in the first 24 hours 
post fertilization (hpf), all major organs form and within 3 days the fish 
hatches. After three to four months the fish are sexually mature and ready 
to generate new offspring. A single zebrafish female can lay up to 200 eggs 
in a week. A great advantage of using the zebrafish as a model for 
embryonic development is that zebrafish embryogenesis is very similar to 
the higher vertebrates, including humans. However, unlike mammals, it 
develops from a fertilised egg to an adult outside the female in a 
transparent egg. This means that it is possible to observe the developing 
embryo in its natural environment. Moreover, the embryos themselves are 
transparent during the first few days of their lives, so researchers can 
observe the formation of internal organs live inside the living organism 
(Fig. 1.2). The use of zebrafish as a model also has advantages from a 
genetic point of view, as many mutations that disrupt embryonic 
development have now been identified, many of which may serve as 
models for human diseases (van Heyningen 1997; Zon 1999; Barut and 
Zon 2000; Dodd et al. 2000; Dooley and Zon 2000; Yan and Gu 2013). 
These mutants will help us to understand the genetic network controlling 
the development of vertebrates, including humans. 
 
Figure 1.2 Zebrafish embryos 24 hours post fertilization (Credit: 
Flickr.com, picture by WithoutFins). 
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1.1.2. Stages of Embryonic Development in Zebrafish 
A study published by Kimmel et al. in 1995 describes extensive studies on 
the morphological changes that define the zebrafish body plan during the 
first three days of embryonic development. Here I describe the 
developmental changes occurring in first 24 hpf of the zebrafish embryos, 
adapted from this study (Kimmel et al. 1995).  
The zebrafish egg consists of a cytoplasm and yolk floating within a 
prospective chorion. After fertilization, which occurs at the prospective 
animal pole, the cytoplasm divides from the yolk and becomes the 
blastodysc, which sits upon the yolk syncytium, and defines the animal-
vegetal axis. From this moment every 15 minutes (min) numerous rapid 
meroblastic cleavage divisions occur synchronously and give rise to a 
blastoderm, which is formed by cells called blastomeres (Fig. 1.3). The 
blastomeres perch on top of the yolk as a mound of cells by the 128 cell 
stage, which is the blastula stage. This continues until approximately 4 hpf. 
During the blastula stage several important processes take place, such as 
the mid-blastula transition (MBT), which occurs at the 512-cell stage and 
defines the beginning of zygotic gene expression (Fig. 1.3). Maternal 
factors drive early developmental processes before MBT, although it is 
possible that a few zygotic genes are also transcribed prior to MBT. 
Moreover, cell cycles lengthen and become asynchronous and complex 
morphogenetic rearrangements begin (Kane and Kimmel 1993; Kimmel et 
al. 1995). At the interface between the yolk and the blastoderm the 
multinucleate yolk syncytial layer (YSL) takes shape, as the cells at the 
margins fall into the yolk. At this point a process called epiboly starts: the 
morphology of the blastoderm changes and it forms a multi-layered cup 
which, together with the YSL, thins and spreads radially over the surface of 
the yolk by complex streaming movements. Epiboly, a process that defines 
the beginning of the late blastula stage, occurs approximately 4 hpf and 
continues until the late gastrula stage. A largely used method for indicating 
developmental stages is the measure of the percentage of the enveloped 
yolk during epiboly. At 50% epiboly (5 hpf) another process, called 
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gastrulation, begins              (Fig. 1.4B):  blastoderm cells at the leading 
edge/margin converge from more lateral/ventral regions, 
involute/ingress (internalise) and extend (Kimmel et al. 1995). Because 
this process of convergence occurs at a specific single point, this area 
becomes thicker and breaks radial symmetry (Fig. 1.4C); this area is now 
the dorsal part of the embryo       (Fig. 1.4 D, E). This thickening become 
clearly visible by 60% epiboly and is called the shield (Fig. 1.6). It 
corresponds to the position of the dorsal embryonic organizer (the 
functional equivalent of the Xenopus Spemann-Mangold organizer (see 
following paragraph for further description). During gastrulation 
involuting cells converge mediolaterally and extend towards the yolk and 
then upwards towards the animal pole thereby elongating embryonic 
tissue anterioposteriorially underneath the overlying blastoderm (Kimmel 
et al. 1995), (Fig. 1.5). Through this process two layers are formed within 
the proper embryo. The involuting cells form the hypoblast/mesendoderm 
(the prospective mesoderm and endoderm) which lies underneath the 
epiplast (the prospective ectoderm). Both gastrulation and epiboly finish 
by the late gastrula stage (10 hpf), when the yolk is completely 
surrounded by the three germ layers of cells which are now positioned at 
their final anteroposterior and dorsoventral locations; ectoderm is the 
outer layer, mesoderm is the middle layer and endoderm is the internal 
layer (Fig. 1.4 D). By 24 hpf CNS structures are apparent (Kimmel et al. 
1995). 
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Figure 1.3. Zebrafish embryo developmental stages. The hours post 
fertilization (hpf) indicated are to be considered approximated as they can 
vary due to different reasons such as, for example, the temperature of 
incubation (pictures adapted from Cebra-Thomas,  2004 
http://www.swarthmore.edu/NatSci/sgilber1/DB_lab/DB_lab.html). 
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Figure 1.4 Movements of the cells during gastrulation in the zebrafish embryo: blastoderm 
at 30% epiboly (A); at 50% epiboly the involution of the cells at the margin of the 
blastoderm create a thickened area were the embryonic shield is loclised (B, C); the 
embryonic shield corresponds to the region that later becomes dorsal part of the embryo (D, 
E). (Figure adapted from Gilbert 6th ed.). 
Figure 1.5 Dorsal view of the cell movements that occur during gastrulation in zebrafish 
embryo. Epiboly moves the blastoderm over the yolk, involution generates the hypoblast. 
Starting from 50% epiboly convergence and extension movements bring the epiblast and 
hypoblast (mesendorem) cells towards the dorsal region, forming the organizer. (Figure 
adapted from Gilbert 6th ed.). 
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1.1.3. The Role of the Organizer During Development 
In zebrafish the formation of the organizer, also known as embryonic 
shield, is an essential process for the establishment of dorsal-ventral 
patterning and the induction of neural cell fate. In the following paragraph 
I briefly describe the molecular mechanisms that regulate this process 
(Appel 2000; Schier and Talbot 2005).  
The firsts understanding of the mechanisms involved in organiser 
formation came, as in many other biological studies, from the investigation 
of mutants. Dorsalised (expansion of neural tissue) and ventralised 
(reduction of neural tissue) mutant phenotypes have been investigated 
through large scale mutagenic screenings (Driever et al. 1996; 
Hammerschmidt et al. 1996; Mullins et al. 1996). The mutations that were 
causing these phenotypes were mapped in genes that are part of the 
canonical Wnt/β-catenin pathway (Kelly et al. 2000) and the Bone 
Morphogenetic Protein (BMP) pathway (Hammerschmidt et al. 1996; 
Hammerschmidt et al. 1999). These pathways are essential for the 
establishment of the right patterning of the dorsal-ventral axis (Appel 
2000; Schier and Talbot 2005). 
Figure 1.6 At 60% epiboly the thickening 
corresponding to the embyonic shield becomes visible 
at the dorsal side of the embryo (white arrows). Lateral 
view (A) and view from the animal pole (B) of a 60% 
epiboly embryo (Stemple 2005). 
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When the Wnt/β-catenin signalling pathway is activated at the dorsal side 
of the zygote, β-catenin accumulates in the nucleus, displaces the co-
repressor Groucho and partners with members of the TCF/LEF family of 
transcription factors, thus activating the expression of target transcription 
factors genes (Fig. 1.7). These genes include bozozok (also known as 
dharma) and the nodal-related extracellular signalling molecule squint, 
whose function is crucial for the formation of the presumptive mesoderm. 
The Wnt/β-catenin signalling pathway overlaps with the Nodal signalling, 
thus defining a specific region on the dorsal part of the embryo called 
Nieuwkoop Centre. The Nieukoop Centre, which is located in the area 
corresponding to the presumptive endoderm (in the vegetal part of the 
embryo), induces the formation of the embryonic shield. This is a small 
group of cells located at the dorsal mesoderm edge, and it is functionally 
equivalent to the Spemann/Mangold organizer found in Xenopus (Saúde et 
al. 2000; Niehrs 2004) and to the primitive node found in mouse 
(Beddington 1994; Shih and Fraser 1996). The zebrafish organizer, as well 
as the Xenopus Spemann/Mangold organizer, can induce the formation of a 
secondary body axis (including neural tissue and mesoderm) if 
microsurgically transplanted to the ventral region of another embryo 
(Shih and Fraser 1996; Driever et al. 1997; Spemann and Mangold 2001). 
A key function of the organizer is to act as a regulatory element 
determining the dorsal fate of the ectoderm cells by secreting dorsalising 
signals. These signalling factors are secreted outside of the cells and act in 
the dorsal region antagonizing BMP such as Bmp2b/7, which are 
ventralising signalling molecules. Bmp activates the expression of different 
genes in a concentration-dependent fashion, thus acting as a “morphogen”. 
Some examples of the proteins expressed in the organizer are Chordin, 
Noggin and Follistatin; they prevent BMP signals from binding DNA and 
thus induce the cells to become organizer, and then notochord, tissue. 
Moreover Bozozok, which is induced by the Nieukoop-Centre, represses 
Bmp2b (Leung et al. 2003) as well as the ventralising signals activated by 
Bmp2b, such as vox/vent/ved (repressors that inhibit Boz and Chd). This 
results in a de-repression of the organizer genes (such as Chordin) 
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mediated by Boz. The dorso-ventral regions that give rise to the 
neural/non-neural ectoderm is defined by the resulting gradient of BMP 
morphogens. The establishment of the neural/ectodermal fate is described 
by the “neural default model” (Munoz-Sanjuan and Brivanlou 2002) 
according to which ectodermal cells are destined to become neural cells 
unless they are targeted by BMP signals, which is prevented in the dorsal 
region by mesoderm secreted factors such as Chordin (Fig. 1.8). This 
means that the organizer induces dorsal fate by secreting dorsalizing 
factors that block the ventralising BMP proteins, rather than inducing it 
directly (Linker and Stern 2004; Stern 2005; Stern 2006). In the region 
where the ventralizing factors are absent, which in other words is the 
presumptive ectoderm, there is accumulation of transcription factors that 
induce neural fate (Mizuseki et al. 1998; Kudoh et al. 2004; Dee et al. 
2007). 
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Figure 1.8 The neural default model. According to the “neural default model” ectodermal cells 
are destined to the neural fate unless they are targeted by ventralising BMP signals, which act in a 
concentration-dependent fashion. In the dorsal region corresponding to the organizer, dorsalizing 
signals, such as chordin, block BMP signalling and thus indirectly induce neural fate. 
Figure 1.7 Activation of the Wnt/β-catenin pathway in the dorsal side of the zebrafish 
embryo. Areas of the embryo that correspond to the Nieukoop Centre and to the organizer (A). In 
the organizer the activation of Wnt signalling and the nuclear localization of β-catenin determine 
the transcriptional activation of target genes through the displacement of the co-repressor Groucho 
and the binding to TCF/LEF operated by β-catenin. The activated target genes include bozozok and 
squint, which activate goosecoid and chordin (B). 
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1.2. The Sox Family 
1.2.1. The Family History 
In the late 1980s many laboratories were investigating the identity of the 
so called “testis-determining factor” (Tdy or TDF), a gene located on the Y 
chromosome that was thought to be responsible for the switch in 
developmental fate occurring in mammals from the default ovarian 
pathway to that of the testis (Koopman et al. 1991; Hacker et al. 1995; 
Collignon et al. 1996). The gene was finally identified as the “Sex 
Determining Region of the Y chromosome” (Sry), which encodes for a 
transcription factor containing a 79 amino acid DNA-binding domain, the 
High Mobility Group box (HMG-box), which participates in DNA binding 
and in some cases also in interactions with partner proteins 
(Chakravarthy et al. 2008). The HMG-box derived its name by the original 
technique used for sorting proteins closely associated with the DNA: the 
electrophoresis of denatured proteins through an agarose gel (Lefebvre et 
al. 2007), which showed that the peptides carrying the HMG-box travelled 
further than other proteins and thus determined the denomination “High 
Mobility Group”. The Sry gene later became the founding member of the 
family of genes known as the Sox family, initially discovered through 
homology comparisons between the human and the mouse Sry genes 
(Gubbay et al. 1990; Sinclair et al. 1990; Denny et al. 1992; Denny et al. 
1992; Lefebvre et al. 2007). On the basis of sequence homology with the 
Sry HMG-box about thirty other Sry-related genes were later discovered 
and named “Sry-related HMG-box” (Sox) and numbered chronologically 
with their discovery, the first to be named were Sox1, Sox2 and Sox3. 
1.2.2. The Members of the Family 
The nomenclature of the members of the Sox family includes a number 
indicating the chronological order of discovery and in some cases a prefix 
indicating the species.  
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All the genes identified as part of the Sox family have a minimum of 50% of 
sequence similarity with respect to the HMG-box of Sry. In an extensive 
evolutionary analysis Bowles et al. recognised ten Sox groups (named A-J) 
based on previous studies as well as full-length protein structure, HMG 
domain sequence similarity (Fig. 1.9) and structural characteristics such 
as intron-exon gene organization (Gubbay et al. 1990; Wright et al. 1993; 
Pevny and Lovell-Badge 1997; Bowles et al. 2000; Schepers et al. 2002). 
Subgroup A contains mammalian proteins, the members of the subgroups 
B, C, D, E and F are found in a large number of metazoan taxa (Jager et al. 
2006; Larroux et al. 2008) and the subgroups G to J contains members that 
are specifics for particular lineages (Zhong et al. 2011). 
Each one of these subgroups is composed of members with a sequence 
similarity of between 60% and 90% (Bowles et al. 2000; Kamachi et al. 
2000) and while some of them are species-specifics, others can be found in 
a wide range of organisms (Wegner 1999; Bowles et al. 2000; Wegner 
2010). About twenty Sox genes were found in the mouse as well as in the 
human genome (Schepers et al. 2002). The majority of vertebrate family 
subgroups have been found to be represented in invertebrates by a single 
Sox gene (Wegner 1999; Bowles et al. 2000).  
Except for the similarity in the HMG-box sequence, the members of distant 
subgroups have high variability in the rest of their sequences (Bowles et 
al. 2000), while the Sox proteins that belong to the same subgroup often 
show functional redundancy when they are co-expressed. This can be 
explained by the presence of conserved structural domains outside the 
HMG-box (Fig. 1.10), (Bowles et al. 2000). Such domains are localised at 
the C-terminus of the proteins and are implicated in transcriptional 
regulation.  
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Figure 1.9 Unrooted phylogeny tree of the Sox HMG domain. Branch lengths are representative 
of the extent of divergence. For groups of presumed mammalian orthologues (other than group A—
Sry), only one representative is indicated. Different groups (A-J) are written with different colours. 
The insert shows group B, which contains the subgroups B1 and B2. Invertebrate sequences are 
underlined. Abbreviations: al, Alligator mississippiensis (alligator); ce, Caenorhabditis elegans 
(nematode); ch, Gallus gallus (chicken); dr, Drosophila melanogaster (fruit-ﬂy); du or d, Sminthopsis 
macroura (marsupial); fu, Saccharomyces cerevisiae (fungi); hu or h, Homo sapiens (human); mo or 
m, Mus musculus (mouse); or, Pongo pygmaeus (orangutan); pi or p, Sus scrofa (pig); ra or r, Rattus 
norvegicus (rat); tw, Macropus eugenii (marsupial); sh or s, Ovis aries (sheep); tr, Oncorhynchus 
mykiss (rainbow trout); se, Strongylocentrotus purpuratus (sea urchin); xe, Xenopus laevis (frog); zf, 
Danio rerio (zebraﬁsh). Image from Bowles et al. (2000). 
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Figure 1.10 Schematic representation of some of the members of different groups (and 
subgroups) of Sox family proteins that highlights the structural conservation of functional 
domains and gene organization. Demonstrated and putative structural domains are shown. 
Picture from Bowles et al. (2000). 
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1.2.3. DNA-binding Property of the Sox Proteins 
All the members of the Sox family share high level of similarity and are 
thought to function as transcription factors (Laudet et al. 1993). The Sox 
proteins contain a single canonical HMG domain composed of 79 amino 
acids that contains the conserved sequence motif “RPMNAFMVW”; this 
motif differentiates the Sox proteins from the other members of the HMG 
superfamily. Due to the presence of the HMG domain, Sox proteins are able 
to recognise and bind specific sequences of DNA. In particular they bind to 
the consensus sequence “5’-WWCAAW-3’” (where W=A/T) (Harley et al. 
1994). However some of these proteins, such as Sox9, showed a higher 
binding preferences for slightly different consensus sequences (Mertin et 
al. 1999). The secondary structure of the HMG-box is composed by three 
α-helices and one β-sheet forming a “L” shape which binds to the minor 
groove of the DNA helix (Fig. 1.11), (van de Wetering and Clevers 1992; 
Read et al. 1994; Weiss 2001; Lefebvre et al. 2007). This binding process is 
a unique feature of the HMG-box as it causes a widening of the minor 
groove that leads to the bending of the DNA structure (Fig. 1.12), (Ferrari 
et al. 1992; van de Wetering and Clevers 1992; Lefebvre et al. 2007). In 
fact the majority of the DNA-binding proteins bind to the major DNA 
groove and cause minor changes in its spatial conformation, by contrast 
the binding of the HMG with the minor groove can bend the DNA with an 
angle from 30 to 110 degrees depending on experimental conditions 
(Ferrari et al. 1992; Connor et al. 1994; Pontiggia et al. 1994; Kamachi et 
al. 1999; Kamachi et al. 2000; Weiss 2001). Such characteristic can be 
explained if we consider that the conformation adopted by the DNA might 
render it more accessible to other proteins. For this reason it has been 
proposed that Sox factors function as architectural transcription factors 
that recruit other protein through their binding to the DNA. According to 
this model the proteins recruited would be other transcription factors, 
chromatin re-modellers or other regulatory partners that would act co-
activating (or co-repressing) target genes (Pontiggia et al. 1994). 
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Figure 1.12 Three-dimensional PDB model of mouse Sox2 binding and bending 
DNA. The presence of three α-helices and a β-sheet give to the domain a characteristic 
“L” shape. As a result of the binding, the DNA helix result to be dramatically bended of 
about 90˚. Picture from Chakravarthy et al. (2008).  
Figure 1.11 Three-dimensional representation of mouse Sox2 HMG domain 
binding its target sequence on the FGF-4 HMG/POU cassette (indicated in red). 
The HMG domain is composed by three α-helices and a β-sheet (pictured in green) and 
binds to the minor groove of the DNA which participate in DNA binding as well as 
interactions with partner proteins.  Hydrogen bonds are indicated as white dotted 
lines. Picture from Chakravarthy et al. (2008).  
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1.2.4. Transcriptional Regulation Activity of the Sox 
Proteins 
It has been demonstrated that Sox proteins also function as classical 
transcription factors regulating the expression levels of target genes 
(Pevny and Lovell-Badge 1997). They are mostly described as activators of 
target gene expression. Many of them contain a trans-activation domain at 
the C-terminus, and this includes the SoxB1 proteins (Kamachi et al. 1995; 
Kamachi 1996; Kamachi et al. 1998; Kamachi et al. 1999; Chakravarthy et 
al. 2008), SoxC proteins (van de Wetering et al. 1993; Chakravarthy et al. 
2008), SoxE proteins (Bell et al. 1997; Ng et al. 1997; Kamachi et al. 1999; 
Chakravarthy et al. 2008) and SoxF (Chakravarthy et al. 2008). If these 
proteins are deleted at their C-terminus and fused to VP16 (a 
transactivation domain constitutively active), they function as activators, 
which is in contrast with the fusion with repressors domains (Koster et al. 
2000; Bylund et al. 2003; Wegner 2010). However some of the Sox factors, 
for example the SoxB2 group (Uchikawa et al. 1999), act as transcriptional 
repressors. 
1.2.5. The Sox Proteins: a Family of Flexible 
Transcription Factors 
All the Sox proteins bind to the DNA by recognizing a specific motif that is 
present many times throughout the whole genome. This consensus motif 
is quite short and degenerate (Wegner 2010). Moreover, the specificity 
with which the HMG-box domains of these different Sox proteins bind and 
bend the DNA is comparable when they are tested in the same in vitro 
conditions (Kamachi et al. 1999; Mertin et al. 1999; Kamachi et al. 2000). It 
has been shown that there may be several Sox factors able to bind a 
certain site in vitro, but when tested in vivo only one of them is still able to 
bind that site. For example, although Sox1, Sox2, Sox3 and Sox9 have been 
shown to have a C-terminal capable of acting as transactivation domain 
(Ng et al. 1997; Kamachi et al. 1999; Kamachi et al. 2000), they do not bind 
DNA with sufficient affinity compared to the classical transcription factors 
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(Lefebvre et al. 2007). Therefore, theoretically they would not be able to 
bind the DNA and act as transcriptional regulators in vivo (Kamachi et al. 
2000). Moreover, given that Sox factors elicit their function in many of 
different tissues, cell types and developmental stages and that in mammals 
only twenty of them have been identified in spite of the high number of 
functions that they have, it is logical to think that they must be strictly and 
specifically regulated. Given all this, how is it then possible for each of the 
Sox factor to act in a cell-specific way activating (or in some cases 
repressing) specific target genes (Kamachi et al. 2000)? 
It is logical to think that Sox factors have to be necessarily flexible in order 
to function in many diverse contexts as they were passepartout regulators 
(Wegner 2010). This can be explained by the interaction of these proteins 
with co-factors, whose presence would be regulated in a developmental 
stage- and cell-specific fashion. According to this model the transcriptional 
regulation activity of the Sox proteins could function only when the 
proteins and the specific co-factors are co-expressed. Each specific 
partnering between a given Sox protein and a given co-factor would 
therefore regulate specific target genes and regulate different processes, 
as for example cell differentiation, in a cellular, tissue and temporal-
specific fashion (Fig. 1.13). Moreover, this could explain why the Sox 
proteins that in vitro have been shown to bind the DNA loosely, on the 
other hand act as effective transcription factors in vivo. Therefore, the Sox 
proteins contain regions that specifically recruit different co-factors 
depending on the context (Kamachi et al. 2000; Wilson and Koopman 
2002). Because of the high homology between the HMG-box domains, it is 
thought that such motifs would be generally present in the rest of the 
sequence, which is highly variable. Sox factors that belong to different 
subgroups and act as trans-activators have low homology in their primary 
structure, and this could be explained by the necessity of recruiting 
different partners (Wegner 2010). For example, the C-terminal region of 
Sox2 recruits p300 and partners with OCT3/OCT4 to activate the enhancer 
fgf4 (Bernadt et al. 2004; Wegner 2010). Some contexts in which Sox 
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protein action is dependent on the cell-specific presence of co-factors have 
already been identified. For example, Sox2 (a member of the SoxB1 
subgroup) is implicated in lens development, but it can recognise the DC5 
target enhancer and regulate this process only when interacting with Pax6 
(Kamachi et al. 2001; Inoue et al. 2007). Through Chromatin 
Immunoprecipitation (ChIP) techniques it has been demonstrated that 
Sox2 and Pax6 are not able to bind DC5 enhancer stably when alone, but 
they do so only when co-expressed, as during normal lens development 
process (Kamachi et al. 1995; Kamachi 1996; Kamachi et al. 1998).  
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Figure 1.13 (A) Different members of some of the groups (and subgroups) of the Sox family 
of transcription factors. The name of the groups is indicated in black, the group B contains the 
two subgroup B1 and B2. (B) Some examples of how Sox proteins partner with specific co-factors in 
order to determine cell differentiation. The figure represents the interactions between some of the 
Sox proteins and various co- factors, the target genes selectively activated as a result of the 
interactions,  and the results in terms of cell differentiation. Picture drawn from image on Graduate 
School of Osaka University website (http://www.fbs.osaka-u.ac.jp/eng/labo/06/). 
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1.3. The SoxB Group 
1.3.1. Classification of the Members of SoxB Group 
The SoxB subgroup of transcription factors, which include Sox1, Sox2, 
Sox3, Sox14 and Sox21, plays a central role in several processes during the 
embryonic development of vertebrates and insects, such as neurogenesis, 
gonadogenesis and morphogenesis (Nambu et al. 1996; Soriano and 
Russell 1998; Uchikawa et al. 1999; Lefebvre et al. 2007; Phochanukul and 
Russell 2010). 
Sox1, sox2 and sox3 belong to this group and they were the first sox genes 
to be isolated and characterised as Sry-related (Gubbay et al. 1990). In 
addition to these three genes two others were later classified in the same 
subgroup because of the high sequence homology of their HMG-box 
domains: sox14 (Wright et al. 1993) and sox21 (Rex et al. 1997). However, 
a further subdivision into subgroups SoxB1 and SoxB2 has been proposed 
on the basis of the full-length sequence alignment and the different roles 
of these proteins in chick (Uchikawa et al. 1999) as well as in other 
vertebrates (Bowles et al. 2000). The homology of the full-length 
sequences is high in proteins belonging to the same subgroup, but there is 
no similarity between the sequences of proteins of different subgroups, 
except for the HMG-box domains and a short proximal C-terminal region. 
Therefore, the similarity between the sequences outside the HMG-box of 
members of the different SoxB subgroup (SoxB1 and SoxB2) is low as it is 
for the members of different Sox groups; for this reason the phylogenetic 
analysis of the SoxB1 and SoxB2 members have been largely based on the 
HMG-box sequences (Zhong et al. 2011).   
In zebrafish the SoxB1 subgroup contains other two members: Sox 19a 
(Sox19) (Vriz and Lovell-Badge 1995) and Sox19b (Sox31) (Girard et al. 
2001), which have been identified as orthologues of Sox15 (which belong 
to the mammalian SoxG group) and are thought to derive from a further 
genome duplication event (Okuda et al. 2006; Okuda et al. 2010).  
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1.3.2. Roles of the Members of SoxB Group 
Regarding the functions of SoxB proteins, SoxB1 transcription factors are 
generally considered to act as activators, while SoxB2 are thought to act as 
repressors. 
SoxB1 proteins contain a C-terminus that act as transcriptional activator. 
However, it has been shown that Sox14 and Sox21 have a putative 
repressor C-terminus domain. This evidence is in contrast with the 
findings on other Sox proteins (Kamachi et al. 1995; Kamachi et al. 1998; 
Kamachi et al. 1999). In fact, it has been shown that they repress the 
expression of the δ-crystalline enhancer DC5, while other SoxB1 members 
activate it in the same experimental conditions (Uchikawa et al. 1999). 
However, it now seems that SoxB1 and SoxB2 can be either activators or 
repressors and that their function is highly dependent on the context of 
when and where they are expressed. This context-dependency could be 
correlated with the interacting partners of the SoxB factors or with post-
transcriptional modifications as, for example, SUOMylation. This is the 
covalent attachment of a short peptide (the SUMO) to a consensus region 
of the protein and it is thought to be correlated to this switch between 
transcriptional activation and repression functions of the SoxB factors 
(Savare et al. 2005; Savare and Girard 2005; Taylor and Labonne 2005; 
Haldin and LaBonne 2010)  
1.4. The SoxB1 Subgroup 
Compared with all the other Sox factors, the members of the SoxB1 
subgroup show higher sequence conservation (Bowles et al. 2000). 
Moreover, their functions are conserved during evolution as they are all 
involved in the process of differentiation of the cells towards the neural 
fate and the specification of the neural tissue. The expression pattern of 
these proteins during the early stages of embryonic development is also 
conserved.  
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Some SoxB1 factors are maternally-derived and they regulate axis 
formation by modulating the expression of nodal-like proteins. This has 
been shown to be the case for Xenopus Sox3 (Zhang et al. 2003; Zhang et al. 
2004; Zhang and Klymkowsky 2007), of mouse Sox2 (Avilion et al. 2003) 
and Sox3-Sox19b in zebrafish (Okuda et al. 2006). 
Sox1, Sox2 and Sox3 proteins were found to be present in the dividing 
neuroepithelium of metazoans embryo during CNS development. It had 
been demonstrated that their co-expression is crucial for maintaining the 
proliferative potential of these multipotent progenitor cells by blocking 
their differentiation. Accordingly, when these neuroepithelial progenitor 
cells start to differentiate and the post-mitotic neural genes start to be 
transcribed, the expression of SoxB1 factors begin to be down-regulated 
(Collignon et al. 1996; Pevny and Lovell-Badge 1997; Pevny et al. 1998; 
Uchikawa et al. 1999; Wood and Episkopou 1999; Bylund et al. 2003; 
Graham et al. 2003; Kan et al. 2004; Pevny and Placzek 2005). Moreover, 
the constitutive overexpression of these proteins in the neural tube of the 
chicken (Bylund et al. 2003; Graham et al. 2003) or in the neural plate of 
Xenopus (Rogers et al. 2009) inhibits the neural differentiation process 
and leads to an increase in the number of progenitor cells that causes the 
expansion of the population of proliferative stem-like cells. When 
constitutive activator versions of Sox2/3 are over-expressed, they 
suppress the process of neural differentiation with the same extent of the 
wt proteins. On the other hand, overexpression of dominant repressor 
forms of Sox3 has been shown to cause premature exit from the cell cycle 
and neural differentiation of the cells. These data suggests that the SoxB1 
factors inhibit neural differentiation by acting as transcriptional activators 
instead of repressors (Bylund et al. 2003). 
As mentioned earlier, SoxB1 proteins can be maternally-inherited by the 
zygote and their pattern of expression during early stages of 
embryogenesis is evolutionarily highly conserved.  For example Sox3 is 
maternally-inherited in the Xenopus embryo and its regulation of nodal-
like protein expression is essential for the axis formation (Zhang et al. 
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2003; Zhang et al. 2004; Zhang and Klymkowsky 2007), while in the 
mouse embryo Sox2 is maternally-derived in a similar way (Avilion et al. 
2003). On the other hand, some small differences in the spatial and 
temporal patterns of expression of the SoxB1 factors have been identified. 
In fact Sox3 is the first of the SoxB1 proteins to be expressed in 
vertebrates (except for mammals), and while Sox2 starts to be expressed 
in the neurectoderm at the beginning of gastrulation, Sox1 is expressed 
only after gastrulation (Rex et al. 1997; Mizuseki et al. 1998; Wood and 
Episkopou 1999; Nitta et al. 2006).  
SoxB1 factors are thought to be functionally redundant during the 
formation of the CNS because of the high similarity of their primary 
structure and the overlapping patterns of their expression (Collignon et al. 
1996; Pevny and Rao 2003). Miyagi, Masui et al. showed that the 
conditional knockout of Sox2 is compensated by the up-regulation of Sox3 
expression in mouse (Miyagi et al. 2008). Moreover loss-of-function 
experiments demonstrated that that the knockdown of Sox3 in zebrafish 
(Dee et al. 2008) and in Xenopus (Rogers et al. 2009) causes only mild 
defects in the development of the nervous system. The phenotypes that 
result from these experiments affect only the cells (or the tissues) where 
that specific SoxB1 factor is usually expressed alone. For example in 
mouse, mutated Sox1 and Sox3 cause lens fibre and pituitary or cranio-
facial defects (Nishiguchi et al. 1998; Rizzoti et al. 2004; Rizzoti and Lovell-
Badge 2007). In humans, different retinal abnormalities, microphthalmia 
and anophthalmia are due to mutations in the Sox2 gene (Fantes et al. 
2003; Williamson et al. 2006). 
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1.5. Sox 3 
1.5.1. The Importance of Studying Sox3  
At the present little is known about the roles of Sox3 in the earliest stages 
of the embryonic development. Knowing the structure of the protein and 
how it interacts with its co-factors would help to give a clearer picture. 
However, its secondary structure is still unknown (except for the HMG 
domain) and the interacting co-factors are still being identified. Sox3 
amino acid sequence, though, does show high similarity with the other 
SoxB1 proteins, Sox1 and Sox2. As shown in figure 1.14, the physical-
chemical properties of the amino acid sequences are conserved among the 
three SoxB1 factors in zebrafish. This is consistent with the findings that 
SoxB1 factors have overlapping expression patterns and that these highly 
homologous proteins have redundant roles in nervous system 
development (Rogers et al. 2009; Zhong et al. 2011). Therefore the 
understanding of the roles and mechanisms of function of Sox3 is very 
important. In fact, knowing the molecular mechanisms of Sox3 could on 
one hand clarify the earliest events that lead to the formation of the neural 
tissue and, on the other help to understand the mechanisms of action of 
the other SoxB1 factors in the later stages of development. Since Sox3 is 
the first of the SoxB1 proteins to be expressed in several vertebrate 
species, and since its presence was detected at very early stages even 
before the specification of neural and non-neural domains (Rex et al. 1997; 
Dee et al. 2007), it is thought to be a key factor for the subsequent 
development of the neural tissue. 
  
2
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Figure 1.14 Multiple alignment of the amino acid sequences of zebrafish SoxB1 proteins (Sox1, Sox2 and Sox3). The alignment was made using ClustalX2 and shaded, on 
the basis of amino acid chemical and physical properties, using GenDoc. 
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1.5.2. Expression and Roles of Sox3 During Zebrafish 
Development 
Sox3 is one of the first and most generally expressed transcription factors 
during neural development of a huge range of vertebrate species, which 
include the zebrafish (Okuda et al. 2006; Dee et al. 2008), Xenopus (Penzel 
et al. 1997; Zhang et al. 2003; Zhang et al. 2004; Zhang and Klymkowsky 
2007),  chicken (Rex et al. 1997) and mouse (Collignon et al. 1996; Wood 
and Episkopou 1999).  
In zebrafish, as well as Xenopus, Sox3 protein is thought to be maternally-
inherited (Zhang et al. 2003; Zhang et al. 2004) and the mRNA is barely 
detected at 32-cell stage (Okuda et al. 2006). While sox3 transcript is 
detectable in the zygote at the beginning of gastrulation and 
differentiation of the ectoderm towards neural/non-neural fate, sox1 and 
sox2 are not detectable until 30% epiboly (Mizuseki et al. 1998; Nitta et al. 
2006; Okuda et al. 2006; Rogers et al. 2008).  
In particular, sox3 has been showed to be present at the MBT (Mid-
Blastula Transition) and its expression increases throughout the 
developing epiblast by 30% epiboly (Okuda et al. 2006). At the shield stage 
it is uniformly confined at the presumptive ectoderm (Okuda et al. 2006) 
and at the same time it is lost from the prospective mesodermal and 
endodermal cells. At the mid-gastrula stage sox3 expression becomes 
confined to the neural plate (Koyano et al. 1997; Rex et al. 1997; Okuda et 
al. 2006; Dee et al. 2007; Dee et al. 2008). In later development sox3 
expression becomes even more confined and overlaps with the other 
soxB1 factors (sox1-2) maintaining the stem cells pluripotency state 
(Bylund et al. 2003; Graham et al. 2003). The presence of sox3 throughout 
the ectoderm by shield stage has inspired the idea that it could play a role 
in the earliest fate decisions (Dee et al. 2008). In the experiments 
documented by Dee et al. (2008) the ectopic over-expression of Sox3 led 
to the duplication of the central nervous system or to other similar 
phenotypes characterised by the formation of additional neural tissue 
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located at the head or the trunk of the developing embryo. This was 
thought to be due to cell-autonomous effects of the ectopic expression of 
the protein in the ectoderm, which would have promoted the expansion of 
the dorsal cells, fated to differentiate into neural tissue during earlier 
neural induction, towards more ventral regions. A model was proposed 
according to which Sox3 transcription factor directly activates the 
expression of sox2 and sox31 (both of which are markers for neural fate 
specification) and at the same time it directly inhibits gata2 (a non-neural 
marker) thus re-programming the cells towards a neuro-ectodermal 
destiny. Therefore, this re-programming process would be the reason why 
the nervous system expands. Moreover, it has been showed that in 
zebrafish Sox3 acts both as a transcriptional activator and as a 
transcriptional repressor (Dee et al. 2008; Shih et al. 2010; Kuo et al. 
2013). 
1.5.3. Sox3 Acts as Transcriptional Activator During 
Neurogenesis 
It has been demonstrated that in the chicken spinal cord Sox3 acts by 
activating the expression of target genes downstream of the pro-neural 
basic Helix-Loop-Helix transcription factors (bHLH family), and maintains 
the stem-like status of neural progenitor cells (Bylund et al. 2003), 
counteracting proneural proteins (normally directed by bHLH activity). In 
Xenopus, gain-of-function and loss-of-function experiments showed that 
Sox3 acts during primary neurogenesis by directly activating sox2 and 
geminin, two early neural genes, in the absence of protein synthesis, and at 
the same time by indirectly inhibiting the Bmp target Xvent2. The resulting 
phenotypes included an increase of proliferative cells, expansion of the 
neural plate, delay in the neurogenesis process and, subsequently, in the 
neural specification (Rogers et al. 2009). This same effect was caused by 
the expression of the constitutive active form of Sox3 (Sox3HMG-VP16) 
and it is consistent with over-expression experiment conducted in other 
model organisms (Bylund et al. 2003; Graham et al. 2003; Dee et al. 2008).  
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In Xenopus, Sox3 also has an indirect repressor effect on Xvent2, probably 
by inducing the expression of a repressor; in fact, the expression of either 
ectopic Sox3 or Sox3HMG-Vp16 led to a similar repression effect, resulting 
in a decrease of epidermogenesis. This effect was not observed after the 
expression of the dominant repressor form of Sox3 (Sox3HMG-EnR) 
(Rogers et al. 2009). Together, these data suggest that Sox3 plays a role as 
a transcriptional activator during neurogenesis. However, as explained in 
the next paragraph, Sox3 has been shown to act as a transcriptional 
repressor in earlier stages of development. 
1.5.4. Sox3 Acts as Transcriptional Repressor During 
Organizer Formation 
In the Xenopus zygote, Sox3 protein and mRNA are maternally-inherited 
(Zhang et al. 2003; Zhang et al. 2004) and therefore present before the 
specification of the three germ layers. This suggested that Sox3 could play 
a role in the specification of the germ layers (Penzel et al. 1997; Rex et al. 
1997). Accordingly, it has been demonstrated that maternal Sox3 is 
involved in axis formation by blocking mesoderm differentiation during 
the specification of the germ layers (Zhang et al. 2003; Zhang et al. 2004; 
Zhang and Klymkowsky 2007). It has been shown that the expression of 
the constitutive active version of Sox3 (Sox3HMG-VP16), knockdown of 
endogenous Sox3 by morpholinos, or injection of anti-Sox3 antibodies that 
prevented the protein from binding DNA, all caused up-regulation of Xnr5 
(Zhang et al. 2003) and Xnr6 (Zhang et al. 2004), two genes that are 
regulated by endogenous VegT and β-catenin and induce the formation of 
dorsal mesoderm. The data indicate that Sox3 directly binds sites within 
the promoter regions of Xnr5 and Xnr6 and down-regulates their 
expression, resulting in a suppression of dorsal axis specification and 
therefore in ventralised phenotypes. Moreover, it has been demonstrated 
that this is not related with Sox3 ability to inhibit Wnt signalling by 
binding β-catenin or by competing with TCF/Lef (which are transcription 
factors regulated by β-catenin)  (Zorn et al. 1999; Zorn et al. 1999; Zhang 
et al. 2003; Heeg-Truesdell and LaBonne 2006; Sinner et al. 2007). 
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Injection of affinity purified anti-Sox3 antibodies into zebrafish embryos 
resulted in the up-regulation of the nodal-related protein Cyclops and 
gastrulation abnormalities, both of which could be rescued by co-injection 
with mRNA encoding the dominant repressor sox3HMG-EnR or the nodal 
inhibitor cerS (Zhang et al. 2004). These data suggest that Sox3 acts as 
transcriptional repressor of nodal signalling in zebrafish as well as in 
Xenopus.  
Sox3 plays a crucial role in the formation of the zebrafish organizer by 
acting as a transcriptional repressor in multiple steps of this process and 
confining the organizer formation both spatially and temporarily (Shih et 
al. 2010). Ectopic over-expression of Sox3 in the early zebrafish embryos, 
realised by RNA microinjection, caused down-regulation of squint (a 
mesoderm-derived nodal factor), of the organizer marker goosecoid (gsc), 
and of chordin (chd) and noggin1 (nog1), which are BMP antagonists 
produced within the organizer. Moreover, in these experiments also the 
Nieukoop centre marker bozozok (boz, also known as dharma) was down-
regulated by Sox3 ectopic over-expression and this is consistent with the 
observation that in Xenopus Sox3 down-regulates the expression of 
siamosis, whose function corresponds to the zebrafish bozozok (Zhang et 
al. 2003). This repression activity of Sox3 has been demonstrated to be 
direct and not caused indirectly by interference of β-catenin. In fact, over-
expression of Sox3HMG-EnR had the same effects of the ectopic 
expression of wt Sox3 on all the analysed organizer markers, but this was 
found not to be the case of Sox3HMG-VP16. Chromatin 
Immunoprecipitation PCR analysis (ChIP PCR) demonstrated that Sox3 IP 
robustly precipitates a bozozok promoter fragment located 1.3 kb 
upstream of the transcription start region (Shih et al. 2010). The 
expression of dominant negative versions of Sox3, which would block Sox3 
ability to bind its target regions on the DNA, led to ectopic expression of 
chordin, goosecoid, noggin1 and squint into both dorsal and ventral areas 
of the animal pole in embryos 24 hours post-fertilization. The resulting 
phenotypes showed vary levels of axis duplications (Shih et al. 2010). 
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Currently, the molecular mechanisms implicated in Sox3 repression 
function are still not completely solved. It is important to mention that 
recent studies proposed the implication of SUMOylation in the switch 
between Sox3 activation and repression functions (Gill 2005; Gill 2005; 
Savare et al. 2005; Savare and Girard 2005; Taylor and Labonne 2005; 
Fernandez-Lloris et al. 2006; Girard and Goossens 2006; Tsuruzoe et al. 
2006). 
1.6. Aim of the Study 
The aim of the present study was to gain a deeper insight into the 
mechanisms that regulate the ability of Sox3 to act both as a 
transcriptional activator and as a transcriptional repressor in the several 
developmental processes mentioned above (Paragraph 1.5). Since 
previous studies focused on specific regions of the protein, I decided to 
proceed with a more comprehensive approach.  Therefore I designed a set 
of experiments that would allow the functional screening of the whole 
Sox3 amino acid sequence in order to identify and associate specific 
regions of the protein with their function/s.  
The use of zebrafish as animal model for the experiments was due to its 
ease to be cultured and bred, and because its embryos develop fast but at 
the same time are considered to be a good model for studying vertebrate 
early development. The study was focused on the zebrafish Sox3 with the 
awareness of the high level of similarity that it shares with its vertebrate 
homologues both structurally (primary structure) and functionally, in the 
early stages of embryonic development. Therefore it is highly probable 
that the protein has conserved functions and roles in molecular regulation 
in the earliest stages of embryonic development among all the vertebrates. 
In particular, attention was focused on one of the earliest functions of 
Sox3, which is the spatial and temporal regulation of the embryonic 
organizer formation (see Paragraph 1.5.1 for further description), together 
with its involvement in neural fate specification.  
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Because it is known that Sox3 acts as a transcriptional repressor in the 
context of organizer formation (Shih et al. 2010; Kuo et al. 2013), the 
present study aimed to investigate the regulation of the activity of Sox3 
both as a transcriptional repressor and a transcriptional activator. Further 
analyses were performed in order to assess the activator function of Sox3 
in vitro. 
Therefore, the present study has been designed and performed in order to 
build the basis for subsequent, more specific analyses of the relationship 
between Sox3 structure and functions as a transcriptional activator and 
repressor. In particular, I wanted to identify large regions of the protein 
that contain domains or residues essential for regulating the activation or 
repression functions of Sox3, in order to obtain a functional map of Sox3 
that could be useful for subsequent analysis.  
To summarise, the objectives of the present study were: 
1. The design of a strategy that could allow the functional screening of 
zebrafish Sox3 sequence by creating mutant constructs of the 
protein, based on what is known about its structure (Chapter 3.1: 
Design of Recombinant Forms of Sox3 for Structural-Functional 
Analysis);  
2. The development and optimization of a cloning strategy that would 
allowed to obtain all the designed constructs (Chapter 3.2: 
Development of a Deletion Cloning Strategy);  
3. The development and optimization of experimental techniques that 
allowed ectopic over-expression of wt and mutant Sox3 proteins in 
the zebrafish embryos at comparable levels (Chapter 3.3: Protein 
Overexpression in zebrafish Embryo);  
4. The comparison between the effects of ectopic over-expression of 
wt and mutant Sox3 on the development of the Central Nervous 
System (Chapter 3.4: Effects of the Expression of Recombinant Sox3 
on Neural Development);  
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5. The comparison between the functions of wt and mutant Sox3 
proteins in the early stages of development, in particular in the 
context of embryonic organizer formation (Chapter 3.5: Effects of 
the Expression of Recombinant Sox3 on Organizer Formation); 
6. The comparison between the transcriptional activation function of 
wt and mutant Sox3 proteins (Chapter 3.6: Transcriptional 
Activation Function of wt and Deletion Mutant Sox3 proteins).
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2. Materials and Methods 
2.1. Purification of Plasmid DNA 
Bacteria containing pβUT2-zfSox3-HA plasmid were grown overnight at 
37˚C on agar plates containing 1% agarose and 100 µg/ml ampicillin 
(Amp). A single colony was then picked and grown at 37˚C overnight 
shaking in 5 ml of Mu Broth culture medium (Section 6.1.1) with Amp 100 
µg/ml. 
2.1.1. Minipreparation of Plasmid DNA 
Bacteria were centrifuged at 16000 x g for 3 min. Plasmid DNA was 
purified using a GenEluteTM Plasmid Miniprep Kit (Sigma-Aldrich) 
following manufacturer’s instructions. Final elution from the column was 
performed using DEPC water (Sigma-Aldrich) at 37˚C.  
2.1.2. Determination of Quality and Concentration of 
Purified DNA 
DNA concentration was measured with a Nanodrop spectrophotometer 
(ND-1000). Only minipreparations with 260/280 ≥ 1.8 were considered of 
good quality and therefore used for subsequent experiments. The quality 
of purified DNA was then further evaluated by gel electrophoresis using a 
1% (w/v) agarose gel. 
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2.2. PCR Cloning 
2.2.1. Polymerase Chain Reactions 
Primers were manually designed and purchased online from Sigma-
Aldrich. All reagents were mixed in a different area of the laboratory prior 
to the addition of template DNA. The reagents used were the followings: 
Forward Primer (20 μM) 2.5 μl 
Reverse Primer (20 μM) 2.5 μl 
DMSO 1.5 μl 
2X Phusion® Master Mix* 16.5 μl 
Diluted template DNA  2.5 ng 
DEPC water up to 50 μl 
Total Volume 50 μl 
*2X Phusion® High-Fidelity PCR MM w/HF Buffer Master Mix and 100% DMSO by New 
England Biolabs® Inc. 
PCR reactions were performed with the following program on a G-Storm 
machine: 
• Heated lid 110 °C; 
• Hot Start 98 °C 1min; 
• 1st stage: 6 times, 95 °C 5 seconds (sec), 58 °C 10 sec, 72 °C 1min 30 
sec; 
• 2nd stage: 30 times, 95 °C 5 sec, 62 °C 10 sec, 72 °C 1min 30 sec; 
• 3rd stage: 1 time, 72°C 10 sec; 
• Storage: 10 °C. 
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2.2.2. Purification of PCR Products 
PCR reactions were run on 1% (w/v) agarose gel. The bands 
corresponding to PCR product expected size were cut out of the gel and 
DNA was purified using QIAquick Gel Extraction Kit (50). 
Quality and concentration of purified DNA were analysed using a 
Nanodrop spectrophotometer and by gel electrophoresis. 
2.2.3. Phosphorylation and Ligation 
After gel extraction PCR products were phosphorylated before ligation. It 
was performed a negative control lacking of kinase enzyme in order to 
verify that gel extraction excluded all parental plasmid. 
Phosphorylation reactions were performed under the following 
conditions: 
 Control Phosphorylation 
DNA template 50 ng 50 ng 
DEPC water  up to 45 μl up to 43 μl 
 
• Heating at 70 °C for 10 min;  
• Chilling on ice; 
• Addition of: 
 Control Phosphorylation 
T4 Ligase Buffer (10X)* 5 μl 5 μl 
T4 Polynucleotide Kinase* / 20 units (2 μl) 
Total Volume 50 μl 50 μl 
*T4 Ligase Buffer and T4 Polynucleotide Kinase by New England Biolabs® 
Inc. 
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• Incubation at 37 °C for 30 min; 
• Heat inactivation at 65°C for 20 min; 
• Chilling on ice; 
• Storage at -20 °C. 
Ligation reactions of both control and phosphorylated DNA were 
performed under the following conditions: 
DNA template 5 μl 
T4 Ligase Buffer 2 μl 
T4 Ligase* 400 units 
DEPC water up to 20 μl 
Total Volume 20 μl 
*T4 Ligase Buffer and T4 Ligase by New England Biolabs® Inc. 
Reactions were then incubated at 4 °C overnight. 
2.2.4. Transformation and Purification of Recombinant 
DNA 
Competent cells (Alpha-Select Bronze or Gold Efficiency by Bioline 
Reagents Ltd.) were thawed on ice then added with ligation reaction (20 
µl) and gently mixed. They were then placed on ice for 30 min, heated at 
42 °C for 1 min and placed back on ice for 5 min. Transformation reaction 
was added with 1 ml SOC medium and incubated at 37 °C for 1 h. 
After incubation bacteria were pelleted by centrifugation (7000 x g for 3 
min), re-suspended in 100 µl Mu Broth medium (Section 6.1.1) and spread 
onto petri dishes containing a layer of Mu Broth Agar medium (Section 
6.1.2) added with 100 µg/ml Amp. Petri dishes were then incubated at 37 
°C overnight. The same protocol was applied for transformation with 
phosphorylated or negative control (without addition of T4 kinase) DNA. 
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After overnight incubation 4 colonies from each plate were picked and 
growth in 5 ml mu medium added with 100 µg/ml  Amp at 37 °C shaking 
overnight. 
DNA from each colony was purified trough plasmid minipreparation (see 
Paragraph 2.1.1). Quality and Concentration of purified plasmids were 
checked both with electrophoresis and Nanodrop measurement ( see 
Paragraph 2.1.2).  
2.2.5. Assessment of the Clones’ Sequences 
The clones obtained were analysed through the following two steps: 
1) Firstly, a restriction digestion with NaeI was performed to identify 
the recombinant clones. Both wt Sox3 (pβUT2-zfSox3-HA plasmid) 
and mutant forms of Sox3 were digested with NaeI (New England 
Biolabs® Inc.) with the following protocol: 
 
Digestion reactions were incubated at 37 °C for 2 h then analysed.  
2) After the identification of the presumptive mutant clones through 
restriction digestion, sequencing was performed in order to confirm 
the sequences of each of the selected clones. An amount of 0.5 µg of 
each predicted mutant was sent to Source Biosciences 
(http://www.sourcebioscience.com/) for sequencing. Sequencing data 
were read with FinchTV (http://www.geospiza.com/) and the 
 Wt Sox 3 Recombinant 
Buffer  2 μl 2 μl 
DNA ̴0.3 to 0.5 µg ̴0.3 to 0.5 µg 
Nae I (10.000 units/ml) 1 μl 1 μl 
DEPC water up to 20 μl up to 20 μl 
Total Volume 20 μl 20 μl 
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sequences were aligned were using Nucleotide BLAST 
(http://blast.ncbi.nlm.nih.gov/).  
2.2.6. Storage of the Clones Obtained 
Competent cells containing the recombinant plasmid were grown from a 
single colony in 5ml Mu Broth medium (Section 6.1.1) for 16 hours at 37 
°C. Bacteria were subsequently spin down and pellet was resuspended in 
500 µl or 800 µl Mu Broth medium (Section 6.1.1). After mixing an amount 
of 500 µl or 200 µl of 90% glycerol was added in order to obtain 45% and 
18% glycerol stocks. The stocks obtained were stored at -80 °C. 
2.3. In Vitro Transcription 
In vitro transcription was performed on plasmids containing green 
fluorescent protein gene (pCS2nlsGFP, see map in Appendix 6.2), wild-type 
sox3 (wtSox3, plasmid pβUT2-zfSox3-HA, see map in Appendix 6.1) and the 
deletion mutant constructs of sox3 (same plasmid as wtSox3) in order to 
obtain capped RNA for embryo microinjection. 
2.3.1. Digestion and Purification of the Template 
Template DNA was obtained from glycerol stocks (see Appendix 7.1 and 
Appendix 7.2 for the maps of the vectors containing wtSox3 and GFP) of 
from the transformed colonies of competent cells in the case of the mutant 
Sox3 constructs. Glycerol stocks were transported on ice and bacteria 
were scraped and added to 5 ml mu, previously added with Amp, using a 
filtered pipette tip. Cells were grown for 16 hours at 37 °C and then DNA 
was extracted using GenEluteTM Plasmid Miniprep Kit (Sigma-Aldrich).  
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Plasmids were subsequently digested with EcoRI or NotI(New England 
Biolabs® Inc.) according to the following protocol: 
Buffer  8 μl 
DNA 2,5 µg 
EcoRI (NotI for GFP) 2 μl 
DEPC water up to 80 μl 
Total Volume 80 μl 
Digestion reactions were incubated at 37 °C for 2 h, then 1µl of digest was 
run on 1% (w/v) agarose gel in order to check digestion. 
Phenol-Chloroform extract was performed in order to clean digested DNA 
template according to the following protocol: 
1. Addition of 1 vol. Phenol:Chloroform:Isoamyl Alcohol (purchased 
from Sigma-Aldich: Phenol:Chloroform:Isoamyl Alcohol 25:24:1 
saturated with 10 mM Tris, pH 8.0, 1 mM EDTA); 
2. Vortex 3 sec; 
3. Centrifuge at 16000 x g for 3 min; 
4. Transfer of the upper layer into a clean eppendorf tube;  
5. Repetition of steps 1,2, 3 and 4; 
6. Addition of 1 vol. of Chloroform; 
7. Vortex 30 sec; 
8. Spin at 16000 x g for 3 min; 
9. Transfer of the upper layer into a clean eppendorf tube; 
10. Repetition of steps 6, 7, 8 and 9; 
11. Addition of 0.1 vol. NaAc 3M and 2.5 vol. EtOH; 
12. Incubation at -20 °C for 30 min; 
13. Spin at 16000 x g for 30 min at 4 °C; 
14. Rinse of the pellet with ice cold 70% EtOH; 
15. Spin at 16000 x g for 5 min at 4 °C; 
16. Removal of EtOH and air drying of the pellet for 10 min; 
17. Resuspension of the pellet in 10 µl RNAse free H2O; 
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18. Storage at -20 °C. 
After extraction, 1 µl of DNA was run on 1% (w/v) agarose gel in order to 
check it was not lost during proceedings.  
2.3.2. In Vitro Transcription and RNA Purification 
In vitro transcription reactions were performed using mMessage 
mMachine® T3 (for obtaining GFP transcript mMessage mMachine® SP6, 
both by Ambion) transcription kit according to the following protocol: 
Linear template DNA 1 μg 
2 x NTP / CAP 10 μl 
10 x Reaction Buffer 2 µl 
Enzyme Mix 2 μl 
Total Volume 20 μl 
The reaction was incubated at 37 °C for 5 h, and then put on ice while 
running 1 µl of each reaction was tested by gel electrophoresis. 
Phenol-Chloroform Extraction was performed to clean capped RNA as 
follows: 
1. Addition of 115 µl Nuclease-Free H2O (from kit) and 15 µl 
Ammonium-Acetate STOP Solution; 
2. Extraction with 1 vol. Phenol:Chloroform:Isoamyl Alcohol 
(purchased from Sigma-Aldich: Phenol:Chloroform:Isoamyl Alcohol  
25:24:1 saturated with 10 mM Tris, pH 8.0, 1 mM EDTA), vortex 30 
sec then spin at 16000 x g for 3 min; 
3. Extraction with 1 vol. Chloroform, vortex 30” then spin at 16000 x g 
for 3 min; 
4. Addition of 1 vol. isopropanol to precipitate RNA; 
5. Incubation at -20 °C for 30 min; 
6. Spin at 16000 x g for 15 min at 4 °C; 
7. Removal of supernatant, air drying of the pellet and resuspention in 
30 µl Nuclease-Free H2O; 
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8. Run 1 µl on 1% (w/v) agarose gel at 150 volt for 25 min and 
Nanodrop measurement of RNA concentration. 
2.3.3. Storage of Capped RNA 
A 15 µl aliquot of the capped RNA (CAP RNA) was directly stored at -80 °C. 
The remaining 15 µl were diluted with Nuclease-Free H2O to a final 
concentration of 100 ng/µl and stored in 5 µl aliquots at -80 °C.  
2.4. Embryo Injection 
2.4.1. Set Up of Zebrafish and Harvesting of the 
Embryos 
Pairs of fishes were set up in the late afternoon in order to allow them to 
lay fertilized eggs the following morning. Small plastic boxes with mesh 
bottom were fitted into larger boxes and filled with water. A pair of fish 
was placed into each of the plastic boxes, divided from each other by a 
transparent plastic device. The device was removed the following morning 
and after 20 min the fish were removed as well as the top container. The 
embryos, which collected from the bottom container, were washed and 
placed into petri dishes filled with water containing dimethylene blue 
(2ml of 0.1% methylene blue into 1L of water). 
2.4.2. Microinjection of Capped RNA in Zebrafish 
Embryos 
Needles were fabricated by heating and pulling borosilicate glass capillary 
tubes in a micropipette puller device, and then stored in petri dishes on 
top of a small stripe of clay. CAP RNA was thawed on ice then used for 
backloading needles using a microloader pipette. The tip of the needle was 
broken with steel tweezers, then the needle was inserted into the 
microinjector. One-two cell stage zebrafish embryos were aligned on a 
petri dish against a glass microscope slide and then microinjected with 50 
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pg of CAP RNA. The RNA was microinjected directly into the cytoplasm 
(Fig. 2.1). 
 
Figure 2.1 RNA microinjection into Zebrafish 1-cell stage embryos (Credits: Grabner Lab 
website and Dominik Paquet website). 
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2.4.3. Incubation of the Embryos 
Microinjected embryos and their uninjected siblings were incubated all at 
the same time at 28 ˚C for the required time, which ranged from 4.5 hpf to 
24 hpf. 
2.5. Western Blot 
2.5.1. Preparation of Samples for Western Blot 
After microinjection and incubation at 28 ˚C until reaching Sphere Stage, 
30 embryos for each sample were collected and the chorions were 
removed using steel tweezers. Water was removed and replaced with 200 
µl of Deyolking Buffer (55 mM NaCl, 1,8 mM KCl, 1,25 mM NaHCO3 in 
SDW) and embryos were homogenized by pipetting with 200 µl filtered 
pipette tip for 20 times. Samples were then centrifuged in eppendorf tubes 
at 124 x g  for 5 min, supernatant was removed and 30 µl of 2X Laemmli 
Sample Buffer (Sigma-Aldrich) were added to each sample before mixing 
and storing them at -80 ˚C. 
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2.5.2. Preparation of Denaturing Gel and Apparatus for 
SDS-PAGE 
Running gel (12.5% w/v of polyacrylamide) was prepared according to 
the following recipe, poured between two gel plates in a gel castor and 
covered with 70% EtOH: 
Reagent Vol. 
Acryl-Bis 29:1 2.14 ml 
Solution B* 1.43 ml 
SDW 1.44 ml 
APS 10% 75 µl 
TEMED 7.5 µl 
*Solution B: 1.57 M Tris HCl pH 8,8 and 0.4% SDS. 
 
After removal of EtOH a stacking gel (12.5% w/v of polyacrylamide) was 
prepared according to the following recipe and poured over polymerized 
running gel: 
Reagent Vol. 
Acryl-Bis 29:1 0.65 ml 
Solution C** 1.25 ml 
SDW 1.73 ml 
APS 10% 75 µl 
TEMED 7.5 µl 
**Solution C: 0.5 M Tris HCl pH 6,8 and 0.4% SDS. 
 
46 
 
After solidification the gels were transferred into the gel tank, which was 
then filled with SDS Running Buffer (Section 6.2.1). 
2.5.3. Gel Running and Electrophoretic Transfer 
Samples were thawed on ice for 10 min, then boiled at 110 ˚C for 10 min 
on heating block, placed back on ice for 10 min and centrifuged at 124 x g 
for 5 min. Only supernatant was collected and loaded on the SDS gel 
together with 5 µl of ladder (SeeBlue® Plus2 Pre-Stained Standard, 
Invitrogen). When performing western blot with recombinant Sox3 forms, 
half of the supernatant of each sample was loaded into each of two gels. 
This allowed performing the loading control (α-actin) and detecting Sox3 
HA-tagged avoiding superposition of the corresponding bands.  
The gels were run at 40 V until all the samples has reached the running 
gel, then at 90 V until the markers contained into Laemmli Sample Buffer 
(Sigma-Aldrich) had reached the bottom of the gel. The gel were then 
removed and a sandwich was made by putting together sponge, filter 
paper, gel, membrane, filter paper, then sponge again. The sandwich was 
made by soaking all the components in the same Transfer Buffer (Section 
6.2.2), which was later used also to fill the transfer tank. 
The transfer was run either at 35 V overnight or 110 V for 1 h RT. The 
membrane was then removed and washed into 5% Marvel Milk in PBST 
for at least 1 h at RT, with gentle shaking. The primary antibodies (rabbit 
anti-HA or anti-actin for loading control, both purchased from abcam®) 
were diluted 1/4000 in 2% w/v Marvel Milk powder in PBST and used to 
soak the membrane overnight at 4 ˚C gently shaking. The following 
morning the membrane was washed in PBST for 3 times 5 min each gently 
shaking, then it was replaced with secondary antibody (LiCor anti-rabbit, 
purchased from LI-COR®) diluted 1/4000 in 2% Marvel Milk in PBST and 
incubated for at least 1 h RT. After washing with PBST for 3 times 5 min 
each, the membrane was finally scanned using LiCor Scanner. 
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2.6. Whole Mount In Situ Hybridization 
2.6.1. RNA Microinjection 
RNA microinjection was performed as described in Chapter 2.3 together 
with each construct GFP capped RNA (50 pg) was injected. After 
incubation only embryos showing fluorescence under UV light were 
selected and fixed. This was carried on in order to make sure that 
microinjection had been effective for all the embryos analysed.  
2.6.2. Fixation and Storage of the Embryos for In Situ 
Hybridization 
After incubation at 28˚C until the embryos reached the desired 
developmental stage, only viable (and fluorescent) embryos were 
collected, washed once with Phosphate-Buffered Saline containing 0.1% 
Tween20 (PBST) and fixed with 4% Paraformaldehyde (PAF) in 
Phosphate-Buffered Saline (PBS) for a few minutes shaking at RT, then 
overnight at 4 ˚C. 
After fixation embryos were washed four times with PBST, then the 
chorions were removed using steel tweezers and washed with an 
increasing gradient of methanol at RT gently shaking: 
Washing Time 
100% PBST                                 5 min 
25% MeOH + 75% PBST           5 min 
50% MeOH + 50% PBST           5 min 
75% MeOH + 25% PBST           5 min 
100% MeOH                           4x5 min 
Embryos were then stored at -20 ˚C for at least overnight. 
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2.6.3. Preparation of DNA Template for Synthesis of 
Riboprobes 
Cells containing the plasmids with the genes of interest were striped from 
glycerol stocks on petri dishes containing a layer of Mu Broth Agar 
medium (Section 6.1.2) with addition of 100 µg/ml Amp, and then grown 
at 37˚C for 16 h. Single colonies were then transferred into 5 ml Mu Broth 
(Section 6.1.1) added with Amp 100 µg/ml and grown at 37˚C for 16 h 
shaking. Plasmid DNA was prepared as described in Section 2.1. The 
templates were subsequently digested overnight (75 μg DNA in a tot vol. 
of 40 µl) with the required restriction enzyme, and then gel purified 
(GenEluteTM Plasmid Miniprep Kit by Sigma-Aldrich). The concentration of 
template DNA was subsequently checked both running 1 μl on gel 
electrophoresis and with Nanodrop measurement before storage at -20 ˚C.  
Sequencing was performed by sending 0.5 µg of each digested template to 
Source Biosciences. 
2.6.4. DIG-labelled Riboprobes Synthesis 
The following labelling reaction was set up on ice and then incubated for 
3h at 37˚C. 
5x Buffer* 
4 µl 
DTT* 
2 µl 
10X MIX** 
2 µl 
RNasin* (40 u/μl) 
0.5 µl 
Polymerase* 2 µl 
DNA template 
800 ng 
DEPC water 
up to 20 µl 
Total Volume 20 µl 
*purchased from Promega, **purchased from Roche. 
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Probes were cleaned using illustraTM MicroSpinTM G-50 Columns (by GE 
Healthcare), then checked running 1 µl on 1% (w/v) agarose gel at 150 
volt for 25 min and stored at -80˚C after addition of 1 vol. of Hybridization 
Buffer. 
Probes were synthetized for all the following genes: 
Gene Restriction 
Enzyme 
RNA 
polymerase 
Vector 
bozozok (boz) Bam HI T7 pCR II 
chordin (chd) Not I T7 pCS2 
goosecoid (gsc) Sma I T7 pCS2 
n-cadherin (ncad) Xho I SP6 unknown 
notail (ntl) Xho I T7 unknown 
squint (sqt) Bam HI T7 pCS2 
 
2.6.5. In Situ Hybridization 
All the buffers necessary for the experiment were previously prepared 
according to the recipes described in Section 6.3. 
Embryos were rehydrated into PBST through a gradient:  
Washing Time 
75% MeOH + 25% PBST           5 min 
50% MeOH + 50% PBST           5 min 
25% MeOH + 75% PBST           5 min 
100% PBST                              4x5 min 
Then they were washed once for 5 min with 50% PBST + 50% 
Hybridization Buffer and incubated with pre-Hybridisation Buffer for 3h at 
67˚C. 
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The pre-hybridisation buffer was subsequently replaced with 100µl 
Hybridization Buffer containing a 1:200 dilution of probe and incubated 
overnight at 67˚C. The Hybridization Buffer containing the probe was then 
stored at -20 ˚C and reused at least twice. 
The following washings were then performed at 67˚C with occasional 
agitation:  
Washing Time 
100% Hybridization Buffer 1x10 min 
75% Hybridization Buffer + 25% 2x SSC 1x10 min 
50% Hybridization Buffer + 50% 2x SSC 1x10 min 
25% Hybridization Buffer + 75% 2x SSC 1x10 min 
2x SSC 1x10 min 
0.2x SSC 4x15 min 
The following washings were performed at RT gently shaking: 
Washing Time 
75% 0.2x SSC + 25% MABTw                5 min 
50% 0.2x SSC + 50% MABTw                5 min 
25% 0.2x SSC + 75% MABTw                5 min 
100% MABTw                                         5 min 
Blocking was performed with 2% Boehringer Blocking ReagentTM in MAB 
for 1h RT gently shaking. 
This was then replaced with antibody (anti-Dig-AP Fab fragments 1:5000 
in MAB Blocking buffer), shake for 5 min at RT then incubated at 4˚C 
overnight. 
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The following morning the samples were shaken for 1 h at RT, then 
antibody solution was removed and samples were wahsed 8x15 min with 
MABTw .  
The embryos were then equilibrated with BCL buffer III 3 times 5 min 
each at RT. This was replaced with developing buffer containing BCL 
buffer + BM PurpleTM 1:1 and incubated at 4 ˚C protected from light for at 
least overnight or until the colour had developed. The reaction was 
stopped by washing with PBST 20mM EDTA 3 times 5 min each, then the 
embryos were fixed in 4%Paf in PBST for 20 min RT. Paraformaldehyde 
was replaced with PBST by washing 3 times 5 min each and finally the 
embryos were put into 90% glycerol and stored at 4 ˚C.  
2.6.6. Evaluation of Embryos after In Situ Hybridisation 
After in situ hybridization embryos were evaluated by comparison 
between uninjected controls, embryos injected with wt Sox3 and embryos 
injected with the different Sox3 mutant forms under a Nikon SMZ15000 
microscope. Pictures were taken using a Nikon DS-5M camera and the 
Nikon ACT-2U 1.40 software. In order to get objective results the 
evaluation of the stained embryos was always performed with a “blind” 
approach, which included covering the samples’ labels and mixing them 
before analysing. 
2.7. Luciferase Reporter Assay 
2.7.1. Preparation of the Samples 
Embryos were co-injected with 50 pg of GFP CAP RNA, 50 pg of wt/mut 
Sox3 CAP RNA and 5 pg of pGL3-3XSX plasmid (for a map of the plasmid 
see Appendix 7.4). Subsequently they were incubated at 28 ˚C, collected at 
Sphere Stage and visualised with an optic microscope under UV light: only 
embryos that were expressing GFP diffusely and at similar level were 
selected. For each group about 50 embryos were injected and 30 were 
selected for the analysis. The chorion was removed from each one of the 
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selected embryos live using steel tweezers. The embryos were then 
diluted with Passive Lysis Buffer (5X PLB Promega, 5 µl of 1X PLB in SDW 
was used for each embryo), vortex and stored at -80 ˚C for up to one week.  
For each experimental group the experiment was repeated three times, 
each with samples of 10 embryos.  
2.7.2. Luciferase Reporter Assay 
The samples, which contained 10 embryos each, were thawed on ice, 
centrifuged at 16000 x g for 5 min and 35 µl of supernatant was 
transferred into fresh eppendorf tubes. They were then centrifuged again 
at 16000 x g for 5 min and 25 µl of supernatant was transferred into white 
96-well plate. The reading was made with a GloMax luminometer using the 
Luciferase Assay System (Promega).  
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3. Results 
3.1. Design of Sox3 Deletion Mutants for Structure-
Function Analysis  
3.1.1. Introduction 
As described in Chapter 1, Sox3 sequence and functions have been highly 
conserved during evolution. However, at the present time it is still not 
clear which regions of the protein are involved in its different functions as 
a regulator of gene expression at different stages of embryonic 
development. The aim of the present study was therefore to screen 
through the entire Sox3 protein sequence looking for regions involved in 
either organizer repressor function or neural induction function. 
Experiments were designed in order to allow rapid and individual testing 
of the involvement of different parts of the protein in such mechanisms by 
testing the effects of their deletions on target genes and comparing them 
to the effects of wt Sox3.  
3.1.2. Development of a Screening Strategy Based on the 
Evolutionary Conservation of Sox3 
The aim of the study was to find a link between Sox3 structure and 
function in early embryo development. As the three-dimensional structure 
of Sox3 has not yet been solved, the main idea of the project was based on 
the assumption that highly conserved positions in proteins are often 
indicative of structural and/or functional importance (Ashkenazy et al. 
2010). Multiple alignment of the protein sequence of Danio rerio (bony 
fishes), Carassius auratus (bony fishes), Amphiprion melanopus (bony 
fishes), Gallus gallus (birds), Taeniopygia guttata (birds), Mus musculus 
(rodents), Xenopus silurana (frogs), Xenopus laevis (frogs), Pan troglodytes 
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(primates) and Homo sapiens (primates), showed higher grade of 
conservation of some regions of the gene with respect to others (Fig. 3.1). 
 
  
5
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Figure 3.1 Multiple alignment between Sox3 amino acid sequences of Danio rerio (Danio), Carassius auratus (Carassius), Amphiprion melanopus 
(Amphiprion), Gallus gallus (Gallus), Taeniopygia guttata (Taeniopygi), Mus musculus (Mus), Xenopus silurana (silurana), Xenopus laevis (laevis), Pan 
troglodytes (Pan) and Homo sapiens (Homo). Alignment realized using ClustalX2 and GeneDoc. Black shading represents identical residues, grey shading 
represents similar residues and white shading represents different residues. 
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3.1.3. Design of Deletion Mutants of Zebrafish Sox3 
The strategy developed for this study was to delete both conserved and 
non-conserved regions, grouping the amino acids on the basis of 
conserved/not conserved clusters. Deletions of about 20 amino acids each 
were designed in order to cover the entire protein sequence but at the 
same time creating a reasonable number of mutants for a first scan of 
Sox3. The HMG-box domain was not removed nor modified not to affect 
Sox3 DNA binding ability. The total number of mutants designed was 
eleven (Fig. 3.2, Table 3.1 and Appendix 7.4) and they were numbered 
chronologically on the basis of when they were designed. During cloning 
experiments a twelfth clone was created and maintained as a negative 
control during all the following experiments. This clone (Mut12) contains 
the HMG-box domain and about 39 amino acids of the C-terminal region of 
the protein but lacks of the central portion; it was expected to lack most of 
the functions and its over-expression was therefore considered unlikely to 
affect embryo development.   
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Figure 3.2 The eleven deletion mutants of Sox3 designed on the basis of the sequence conservation during evolution. The regions deleted in each 
construct are indicated with different colours and numbered accordingly to the names of the mutants. Multiple alignments were realized using ClustalX2 
and visualised using GeneDoc.  Black shading represents identical residues, grey shading represents similar residues and white shading represents 
different residues. 
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Name Deletion Level of Conservation 
Mut1 P100-G123 Highly conserved region 
Mut2 G140-L163 Medium conserved region 
Mut3 A201-G221 Poorly conserved region 
Mut4 G124-V139 Poorly conserved region 
Mut5 A164-M179 Poorly conserved region 
Mut6 H180-N200 Medium conserved region 
Mut7 A226-G250 Medium conserved region 
Mut8 D251-G263 Highly conserved region 
Mut9 Q273-G290 Poorly conserved region 
Mut10 V291-I300 Highly conserved region 
Mut11 Y2-I3 Quite high conserved region 
Mut12 P100-P122 + 
P128-P261 
- 
 
Table 3.1 Nature of deleted regions of mutant forms of Sox3 that carry deletion in different 
regions of the protein. 
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3.2. Development of a Deletion Cloning Strategy  
Zebrafish Sox3 had been previously cloned into the pβUT2 vector 
including an HA tag downstream the gene in order to allow 
immunohistochemical detection of the protein. The same plasmid was 
used for all the experiments described (Appendix 7.1). The cloning 
strategy was designed to meet two main objectives: firstly to realise 
deletions without altering dramatically the remaining part of the protein, 
and secondly to provide a fast way to screen the clones to identify those 
containing the mutations before sequencing. The strategy was to replace 
the deleted region with a restriction site, so that it could be possible to 
assess the presence of the mutation just performing a restriction digestion 
followed by gel electrophoresis (Fig. 3.3). The enzyme chosen for these 
experiments was NaeI (restriction site 5’GCCGGC3’) as its translation 
produced Alanine-Glycine, amino acids that were expected to have low 
impact on the protein secondary structure.  
The ability of NaeI to cut pβUT2-zfSox3-HA was tested both using NEB 
cutter V2.0 (http://tools.neb.com/NEBcutter2/index.php) and performing 
restriction digestion followed by gel electrophoresis. The test showed that 
the enzyme did not cut the parental plasmid, while it cut the recombinant 
plasmids that contained the restriction site (Fig. 3.4 and Fig. 3.5). 
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Figure 3.3 Schematic representation of the cloning strategy. For each mutant two primers 
were designed: a reverse primer located towards the region of the gene corresponding to the     
N-terminus of the protein, and a forwards primer located towards the region of the gene 
corresponding to the C-terminus of the protein (1). The PCR products obtained (2) with each pair 
of primers were phosphorylated and ligated (3), then used for transforming competent cells that 
were grown on agar plates (4). In order to identify the recombinant colonies, the plasmid DNA 
was purified (5), digested with NaeI and analysed through gel electrophoresis (6). For each of the 
eleven deletion mutants one colony was selected and the exact sequence of each recombinant 
plasmid purified from the selected colonies was subsequently obtained through DNA Sanger 
sequencing (7).  
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Figure 3.5 Gel represented in point 6 of figure 3.3. Light blue arrows indicate the wt plasmid
(pβUT2-zfsox3-HA); green arrows indicate plasmids that were successfully digested by NaeI and 
presumably contain the desired deletion; red arrows indicate plasmids that were not digested by 
NaeI. The first lane corresponds to 1kb DNA ladder (by New England Biolabs®, 0,05 µg), the 
second lane to pβUT2-zfsox3-HA, the third and the fourth lanes correspond to different 
concentrations of pβUT2-zfsox3-HA after digestion with NaeI (same reaction conditions used for
the presumptive mutant plasmids). The four lanes indicated as “Mut1” correspond to the same 
four plasmids represented in Fig3.4 after digestion with NaeI, the four lanes indicated as “Mut2” 
correspond to the same four plasmids represented in Fig3.4 after digestion with NaeI. The 
enzyme proved to partially digest the parental plasmid (this is more evident in the fourth lane, 
which contains high concentration of digested parental plasmid and where three bands are 
visible). This explains why the lanes corresponding to digested mutants contain multiple bands. 
Figure 3.4 Gel represented in point 5 of figure 3.3. The first lane corresponds to 1kb DNA 
ladder (New England Biolabs®, 0,05 µg), the second lane corresponds to the wt Sox3 plasmid
(pβUT2-zfsox3-HA), the folllowing four lanes, which are indicated as “Mut1”, correspond to 
plasmids purified from four different colonies of competent cells transformed with mut1 PCR 
products. The last four lanes, which are indicated as “Mut2”, correspond to plasmids purified 
from four different colonies of competent cells transformed with mut2 PCR products. 
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3.2.1. Primers Design 
For each clone a pair of primers of between 19 and 27 nucleotides was 
designed (Appendix 7.3), so that the primer located towards the                
5’-terminus of the gene (region codifying for the N-terminus of the 
protein) was the Reverse Primer and the primer located towards the        
3’-terminus of the gene (region codifying for the C-terminus of the 
protein) was the Forward Primer (Fig. 3.3). This approach allowed 
performing a single ligation reaction after PCR. Both the Reverse and the 
Forward primers had a “GGC” triplet added at their 5’-end in order to 
obtain the Nae I restriction site inserted in the final transcript. 
3.2.2. Results of the Cloning 
The first part of this project was to design and develop the cloning strategy 
described above. This involved the optimization of the protocol, including 
the testing of different experimental conditions during different steps, 
such as PCR reaction, ligation and transformation. In particular, the 
experiments involved the testing of different volumes of reagents and 
different temperatures for the PCR reaction. Moreover, different ligase 
enzymes and different steps and times of incubation were tested for the 
ligation and phosphorylation reactions. Also the transformation protocol 
was developed through the testing of different conditions, such as the use 
of different types of competent cells. Once the protocol was optimized, all 
the designed mutants were effectively obtained through this cloning 
strategy. Figures 3.6 and 3.7 show, respectively, the nucleotide sequence 
of wt Sox3 and the sequence of one of the deletion mutant constructs 
obtained with the cloning strategy described above.  
The cloning strategy that was developed allowed the creation of large 
deletions and to insert a new restriction site by inserting just minor new 
modifications in the final protein. In fact, the inserted site is translated into 
Alanine-Glycine, small un-charged amino acids. In addition, the deletions 
were designed, when possible, in order to include an Ala, or a Gly, or both 
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at the ends of the deleted regions, so that they would have been replaced 
by the restriction site (Table 3.2). 
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1   ATGTATAACATGATGGAAACCGAGATTAAAAGCCCCATTCCGCAGTCCAA 
51  CACGGGCTCGGTGACGGGCGGCAAAAACAACAGTGCCAACGACCAGGACC 
101 GGGTGAAGCGGCCTATGAATGCTTTCATGGTGTGGTCTCGCGGGCAGCGG 
151 AGGAAGATGGCTCAGGAGAATCCTAAAATGCACAACTCGGAGATCAGCAA 
201 GCGCCTCGGTGCTGACTGGAAACTTTTGACTGACGCCGAGAAGAGACCCT 
251 TCATTGACGAGGCCAAGCGGTTACGAGCCATGCACATGAAGGAGCACCCG 
301 GATTACAAATACCGTCCCCGCAGGAAGACCAAGACCCTGCTGAAGAAAGA 
351 CAAGTATTCTTTGCCAGGGGGACTCCTGGCGCCCGGTGCCAACGCTGTCA 
401 ACAACGCGGTGTCTGTGGGCCAGCGGATGGACTACACGCACATGAACGGA 
451 TGGACGAACAGCGCATACTCCCTCATGCAGGACCAGCTGGCCTACCCTCA 
501 ACATCCCAGCATGAACAGCCCCCAGATCCAGCAGATGCACCGGTACGACA 
551 TGGCGGGACTTCAGTACCCAATGATGTCCACGGCTCAGACCTACATGAAC 
601 GCCGCGTCCACGTACAGCAGCATGTCACCAGCATACACGCAACAAACTTC 
651 CAGTGCAATGGGTTTGGGCTCCATGGCTTCGGTGTGCAAGACGGAGCCCA 
701 GCTCCCCTCCTCCGGCCATAACCTCTCACTCTCAGCGTGCTTGTTTGGGA 
751 GACCTGAGAGATATGATAAGCATGTACCTGCCGCCCGGTGGAGACAGCGC 
801 CGACCACTCCAGTCTACAGACCAGTCGGTTACACAGCGTTCATCCGCACT 
851 ATCAAAGCGCAGGGACAGGCGTGAACGGAACGCTACCCCTAACCCACATT 
First codon of the gene 
HMG domain 
Region to be deleted for creating Mut1 
Last codon of the insert 
 
  
Figure 3.6 Sequence of the wt Sox3 gene inserted in the pβUT2-zfSox3-HA 
vector. The region highlighted in purple indicates the region that is missing in the 
Mut1 construct.  
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1   ATGTATAACATGATGGAAACCGAGATTAAAAGCCCCATTCCGCAGTCCAA 
51  CACGGGCTCGGTGACGGGCGGCAAAAACAACAGTGCCAACGACCAGGACC 
101 GGGTGAAGCGGCCTATGAATGCTTTCATGGTGTGGTCTCGCGGGCAGCGG 
151 AGGAAGATGGCTCAGGAGAATCCTAAAATGCACAACTCGGAGATCAGCAA 
201 GCGCCTCGGTGCTGACTGGAAACTTTTGACTGACGCCGAGAAGAGACCCT 
251 TCATTGACGAGGCCAAGCGGTTACGAGCCATGCACATGAAGGAGCACGCC 
301 GGCGGACTCCTGGCGCCCGGTGCCAACGCTGTCAACAACGCGGTGTCTGT 
351 GGGCCAGCGGATGGACTACACGCACATGAACGGATGGACGAACAGCGCAT 
401 ACTCCCTCATGCAGGACCAGCTGGCCTACCCTCAACATCCCAGCATGAAC 
451 AGCCCCCAGATCCAGCAGATGCACCGGTACGACATGGCGGGACTTCAGTA 
501 CCCAATGATGTCCACGGCTCAGACCTACATGAACGCCGCGTCCACGTACA 
551 GCAGCATGTCACCAGCATACACGCAACAAACTTCCAGTGCAATGGGTTTG 
601 GGCTCCATGGCTTCGGTGTGCAAGACGGAGCCCAGCTCCCCTCCTCCGGC 
651 CATAACCTCTCACTCTCAGCGTGCTTGTTTGGGAGACCTGAGAGATATGA 
701 TAAGCATGTACCTGCCGCCCGGTGGAGACAGCGCCGACCACTCCAGTCTA 
751 CAGACCAGTCGGTTACACAGCGTTCATCCGCACTATCAAAGCGCANGGAC 
801 AGGCGTGAACGGAACGCTACCCCTAACCCACATT 
 
First codon of the gene 
HMG domain 
NaeI site, which replaced the deleted region 
Last codon of the insert 
 
 
  
Figure 3.7 Sequence of  Mut1 obtained through sequencing. The region of the 
wt gene that was deleted has been successfully replaced with the restriction site of 
NaeI (highlighted in yellow), which will be translated in the amino acids Alanine-
Glycine.  
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Name of the construct 
and deleted region 
Length of the deletion 
(nucleotides) 
Residues that replaced 
the deleted region 
Mutant 1 (P100-G123) 24 Ala 
Mutant 2 (V139-L163) 25 Ala-Gly 
Mutant 3 (A201-G221) 21 - 
Mutant 4 (G124-G140) 17 Ala 
Mutant 5 (A164-M179) 16 Gly 
Mutant 6 (H180-N200) 21 Ala-Gly 
Mutant 7 (A226-G250) 25 - 
Mutant 8 (D251-G263) 13 Ala 
Mutant 9 (Q273-G290) 18 Ala 
Mutant 10 (V291-I300) 10 Ala-Gly 
Mutant 11 (Y2-I13) 12 Ala-Gly 
Mutant 12 (P100-P122 + 
P128-P261) 
157 Ala 
Table 3.2 Deletion mutants of Sox3 carrying deletions in different regions of the protein. The 
table indicates the number of nucleotides deleted from each construct and the amino acids that 
replaced the deletion.  
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3.3. Protein Overexpression in Zebrafish Embryos 
3.3.1. A Strategy to Induce Ectopic Protein Expression in 
Early Zebrafish Embryos 
In recent years the use of microinjection to study gene function in the 
zebrafish has become widespread (Rosen et al. 2009) . This includes 
ectopic expression of genes by injecting DNA or RNA into embryos or 
introduction of blocking molecules, such as RNA encoding truncated 
proteins or antibodies, in order to alter the activity of endogenous gene 
products (Paul T. Sharpe and Mason 1999; Dee et al. 2008). The method 
involves microinjection of DNA or RNA molecules directly into the 
cytoplasm of 1-4 cell stage fertilized zebrafish embryos using a pressure 
microinjector and micromanipulator, as described in Section 2.4. DNA 
microinjection results into only a small fraction of the cells within the 
embryo inheriting the foreign DNA, because of the delay in integration and 
rapid cell division of the early zebrafish embryos. Hence, the expression of 
the transgene is highly mosaic and the germ-line transmission of the 
transgene has low efficiency. In the experiments described below 
microinjection of in vitro-synthetized capped RNA was performed in order 
to obtain transient (up to 3 days) and widespread ectopic overexpression 
of Sox3 (or its deleted forms)(Guille 1999).  The aim of using this 
technique instead of DNA microinjection is to obtain rapid translation and 
more readily diffusion of the construct, avoiding mosaic overexpression 
which would have perturbed the analysis (Hyatt and Ekker 1999). In the 
following part of the study, microinjection of capped RNA was used to 
investigate the functional roles of Sox3 by comparing morphological and 
molecular changes in embryos overexpressing the wt protein versus 
mutant forms carrying deletions. 
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3.3.2. Over-expression of wt Sox3 in Early Zebrafish 
Embryos 
Western blot analysis was performed to assess whether microinjection of 
capped RNA resulted in ectopic overexpression of protein in embryos at 
Sphere Stage (about 4 ½ hpf). For assessing overexpression of wt Sox3, 15 
embryos were injected with 50 pg of zfsox3-HA RNA and dechorionated 
live at Sphere Stage (about 4 ½ hpf) together with 15 uninjected embryos 
at the same developmental stage (negative control), followed by SDS 
PAGE. Western blot was performed to detect the HA tag of the ectopic 
Sox3-HA (Fig. 3.8 A) and the membrane was subsequently re-blotted to 
detect endogenous α-actin as loading control (Fig. 3.8 B). The experiment 
lead to a clear detection of zfSox3-HA as well as  α-actin, as demonstrated 
by the existence of strong bands of about 36 and 38 kDa, respectively, thus 
verifying successful ectopic expression of the foreign gene at Sphere Stage. 
HA was not detected in uninjected embryos since it is not endogenously 
expressed in zebrafish. The other bands that are visible in both samples 
were probably due to non-specific binding of the antibodies. 
 
A B 
A B 
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Figure 3.8 Western blot analysis of embryos uninjected (UN) or injected with wt sox3-HA (Sox3) 
at 1-4 cell stage and incubated until sphere stage. Figure A shows detection of HA: the two bands 
seen in both  lanes correspond to non-specific signals, the third strong band in lane 3 corresponds to 
ectopic Sox3. Figure B shows an additional blotting of the same membrane for detecting α-actin as 
loading control (white arrows).  
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3.3.3. Over-expression of Sox3 Deletion Mutants in 
Early Zebrafish Embryos 
Western blot analysis was performed on Sphere Stage embryos 
microinjected with the Sox3 deletion mutants in order to assess whether 
the efficiency of over-expression of the protein products was affected by 
the deletions.  
 An amount of 45 embryos were injected at 1-4 cell stage with each 
construct, including wt sox3-HA and mutants 1 to 12 (all containing HA tag 
fused to the gene), and incubated until they reached Sphere Stage 
(approximately 4 ½ hpf), while 45 embryos were incubated without any 
prior injection to be used as negative control (UN). For each of the 
injection groups 30 embryos were selected, dechorionated live, treated as 
described in Section 2.4.1, then divided into two half and run on two 
separate SDS PAGE gels. The gels were then transferred on two 
membranes, which were incubated respectively with anti-α-actin primary 
antibodies or anti-HA primary antibodies. This approach was used in 
order to avoid any superposition between the bands corresponding to      
α-actin and Sox3, as it could have interfered with the clarity of the blot. 
The Western Blot for HA showed upper bands that were thought to be 
non-specific signals, as they were present in the negative control as well as 
in all the other samples (Fig. 3.10 A) and also in the previous western blot 
experiment (Fig. 3.8). The third lane of the blot, which correspond to the 
wtSox3-HA protein, presented another clear large band, which 
corresponds to the ectopic Sox3. All the lanes corresponding to the 
deletion mutants contained large bands corresponding to the recombinant 
proteins but of various sizes. At the same time another Western Blot was 
performed for each of the samples and incubated with primary antibody 
specific for α-actin (Fig. 3.10 B). This blot served as a loading control and 
confirmed that the amounts of embryos analysed were similar in all the 
samples. 
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Although the blot of the Sox3 deletion mutants was not perfect (there was 
insufficient time to repeat the experiment), the variation in the sizes of the 
bands corresponded well to the sizes of the deletions present in each of 
the constructs microinjected (Fig. 3.10 A, Table 3.2) and the amount of 
protein seemed quite similar in all the samples, except Mut12. Even 
though it is possible that the high intensity of the band corresponding to 
Mut12 was due to the small size of the construct, a higher expression of 
such construct was presumed not to be a problem since this construct was 
a negative control.   
Importantly, this analysis proved that the effects of the over-expression of 
Sox3 mutants showed in the subsequent experiments were not due to the 
absence, or to the modified expression of the Sox3 deletion constructs. 
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Figure 3.10 Western blot analysis of embryos uninjected (UN) or injected with different 
constructs at 1-4 cell stage and incubated until sphere stage. The embryos were kept uninjected 
(UN) or injected with respectively wt sox3-HA (wt), mut1 (1), mut2 (2), mut3 (3), mut4 (4), mut5 (5), 
mut6 (6), mut7 (7), mut8 (8), mut9 (9), mut10 (10), mut11 (11) or mut12 (12). Figure A: detection of 
HA, the number of amino acids deleted in each construct is indicated above. Figure B: loading 
control, detection of endogenous α-actin. 
Figure 3.9 Schematic representations of the deletion constructs that were 
analysed through western blot. The light blue bars indicate the wt gene and the 
blue bars represents the HMG domain. For each construct the deleted region is 
represented as a red bar numbered accordingly to the name of the construct (for 
example 1 indicates the region missing in Mut1).   
98 kDa 
64 kDa 
50 kDa 
36 kDa 
UN wt 1 3 2 4 6 5 8 7 11 9 10 12 
98 kDa 
64 kDa 
50 kDa 
36 kDa 
UN 
A 
B 
wt 1 3 2 4 6 5 8 7 11 9 10 12 
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3.4. Effects of the Over-expression of Sox3 Deletion 
Mutants on Neural Development 
3.4.1. Introduction 
The ectopic expression of wt Sox3 in zebrafish embryos causes a 
duplication of the Central Nervous System (CNS) as demonstrated by 
previous experiments (Dee et al. 2008). In order to investigate whether 
one or more of the regions that were deleted from the protein are involved 
in this phenomenon, and thus might play a role in Sox3 functioning in the 
determination of the neural fate, embryos were analysed 24 hpf after 
microinjection of RNA. In particular, the aim of this experiment was to 
dissect whether the over-expression of the deletion constructs caused 
different effects on the development of the nervous system, compared to 
the effects caused by over-expression of wt Sox3.  In order to allow clear 
visualization of the CNS, the 24 hpf embryos were hybridized with n-
cadherin riboprobes (ncad) by whole mount in situ hybridization. 
Cadherins are a family of Ca2+-dependent cell adhesion proteins that are 
essential during several steps of vertebrate embryo development 
(Takeichi 1988; Halbleib and Nelson 2006). Ncad, in particular, is a 
cadherin implicated in many aspects of development, including the 
formation of the neural tube and it is expressed throughout the developing 
nervous system (Kintner 1992; Klymkowsky et al. 2010). The expression 
of Ncad is quite ubiquitous during early vertebrate development, and only 
at later stages it becomes restricted to specific regions of the CNS. For this 
reason in our experiment we decided to use ncad as a marker for the 
visualization of the zebrafish developing CNS. 
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3.4.2. Ectopic Expression of wt zfSox3 Induces 
Duplication of the CNS 
Firstly, experiments were carried out in order to determine the ideal 
conditions to see clearly the effects of over-expression of wt Sox3 
(wtSox3), compared to uninjected (UN) and GFP-injected control embryos 
(GFP). The reason why a control was performed by injecting embryos with 
only GFP, was to confirm that the phenotypes were not affected by the 
injection procedure itself. Moreover, microinjection of mut12 deletion 
construct was also carried out as negative control, since this mutant was 
expected to have lost Sox3 function. 
The experiment was performed by injecting embryos with 50pg of CAP 
RNA as reported in the literature (Dee et al. 2008; Shih et al. 2010). The 
resulting phenotypes (Fig. 3.11) were divided into four categories: normal, 
when the nervous system was not affected by the experiment (Fig. 3.12 A, 
B, C), mild CNS duplication, when the nervous tissue showed local 
duplication or expansion to a range of extents (Fig. 3.12 D, E, F), severe 
CNS duplication, when the duplication involved most of the length of the 
CNS (Fig. 3.12 G, H, I), and major disruption of neural tissue, when the 
embryo appeared disrupted and in most cases very poorly developed and 
the nervous tissue was very disrupted (Fig. 3.12 L, M, N).  
The results of the experiment were the following (Fig. 3.13 and Table 3.3): 
1) Both the UN and the GFP controls were unaffected by the 
procedure, as they showed 100% normal embryos; 
2) Microinjection of wt sox3 severely affected the development of the 
CNS, as 25% of the embryos showed mild CNS duplication, 71% 
severe CNS duplication and 3% major disruption of the neural 
tissue; 
3) Microinjection of mut12 did not affect the development of the CNS, 
as 100% of the embryos had a normal phenotype, suggesting a total 
loss-of-function of wt Sox3. 
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Since these results showed a clear difference between the phenotypes of 
the controls (UN and GFP) and the phenotypes caused by injection of wt 
sox3, all the subsequent experiments were repeated performing injections 
of 50pg of CAP RNA and whole mount in situ hybridization with N-
cadherin probes. Moreover, the injection of mut12 as a control of the loss-
of-function of wt Sox3 was also repeated. 
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Figure 3.11 Embryos uninjected (A) or injected with wt sox3 (B), fixed 24 hpf and analysed 
through whole mount in situ hybridization for ncad (a neural marker). It is clearly visible how 
the over-expression of Sox3 affected the development of the nervous system as the neural tissue 
appeared much more disrupted in the majority of the embryos shown in picture B compared to 
picture A. 
Figure 3.12 Categories of the phenotypes obtained with whole mount in situ hybridisation
for ncad on 24 hpf embryos uninjected or injected with wt/mut sox3. The four categories 
are: normal (A, B, C), mild CNS duplication (black arrows in figures D, E, F), severe CNS 
duplication (G, H, I) and major disruption of the neural tissue (L, M, N). Each embryo is shown 
from the lateral side (A, D, G, L), from the frontal side (B, E, M) and from the dorsal side (C, F, I, 
N). In picture H the embryo is shown from the dorsal side but slightly turned in order to 
visualize entirely the duplication of the CNS.   
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normal 
mild CNS 
duplication 
severe CNS 
duplication 
major 
disruption of 
neural tissue 
tot 
UN 106 0 0 0 106 
GFP 78 0 0 0 78 
wt sox3 0 16 45 2 63 
mut 12 56 0 0 0 56 
Table 3.3 Numbers of 24 hpf embryos analysed with whole mount in situ hybridisation for ncad. 
The data shown are the raw numbers that correspond to the percentages shown in figure 3.13. 
100% 100% 100%
25%
71%
3%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
UN GFP wtSox3 Mut12
normal mild CNS duplication
severe CNS duplication major disruption of neural tissue
Figure 3.13 Results of whole mount in situ hybridisation for ncad performed on 24 hpf embryos 
respectively uninjected (UN), injected with GFP, wt sox3 or mut12.  
56 78 63 106 
Total number 
of embryos 
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3.4.3. Analysis of Embryos 24 hpf After Microinjection 
of Sox3 Deletion Mutants 
The experiments were carried out in order to analyse whether the over-
expression of the Sox3 deletion mutants caused different phenotypes in 
embryos at 24 hpf compared to those caused by over-expression of wt 
Sox3 (wt Sox3). Two experimental controls were performed: a group of 
uninjected embryos (UN) were treated with the same procedures as all the 
other groups, and a group of embryos were injected with 50pg GFP CAP 
RNA (GFP). The effects caused by all the Sox3 deletion mutants were 
analysed in two separate sets of experiments, as the use of a high number 
of samples for the same experiment could have caused delays in the 
experimental procedures (especially in the whole mount in situ 
hybridisation protocol) and therefore could have affected the results. Both 
the UN and GFP control were repeated in the two experiments as 
microinjection and in situ hybridization can show some variability 
between different experiment and this would have rendered the 
comparison between wt and mutants Sox3 less reliable. The resulting 
phenotypes were assigned to four categories (Fig. 3.14A and Fig. 3.14B): 
normal, when the nervous system was not affected by the experiment; 
mild CNS duplication, when the nervous tissue showed to be locally 
duplicated or expanded in a range of extents; severe CNS duplication, 
when the duplication involved the CNS in all its length; and major CNS 
disruption, when the embryo appeared disrupted and in most of the cases 
not developed and the nervous tissue was completely disrupted. 
Moreover, it has been observed that almost half of the embryos 
microinjected with mut10 presented an additional unique phenotype   
(Fig. 3.15). Because these embryos were characterised by a dramatic 
disruption of the nervous tissue, they were considered to belong to the 
“major disruption of the neural tissue” phenotype. However, it is 
important to note that this phenotype differed from the others in the same 
category. 
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In the first set of experiments, uninjected embryos (UN), embryos injected 
with only GFP and embryos injected with GFP and wt sox3 were compared 
to embryos injected with GFP together with mut2, mut3, mut4, mut5, mut6, 
mut7 and mut12 (Fig. 3.16 ,Table 3.4). The results were as follows: 
1) Both UN and GFP controls exhibited 100% normal phenotypes 
embryos. 
2) Microinjection of wt sox3 resulted in only 3% normal phenotypes, 
while 23% of the embryos presented mild CNS duplication, 55% 
severe CNS duplication and 20% major CNS disruption. 
3) Microinjection of mut2 seemed to cause slightly less disruption of 
the CNS, as 21% of the embryos were normal, 67% had mild CNS 
duplication, 10% severe CNS duplication and 1% major CNS 
disruption. This suggests mild loss of Sox3 function. 
4) The embryos microinjected with mut3 showed 20% mild CNS 
duplication, 57% severe CNS duplication and 23% major CNS 
disruption. These data are comparable to those obtained for the wt 
and suggest that Mut3 did not present loss of function. 
5) Microinjection of mut4, mut5 and mut6 caused phenotypes very 
similar to microinjection of wt sox3. The total amount of embryos 
that were affected was almost the same in all these groups 
compared to wt sox3, as they presented respectively only 14%, 4% 
and 8% of embryos with normal phenotypes (versus the 3% 
presented in wt sox3 injected embryos). However, they did show a 
higher amount of mild phenoypes than wt sox3 (respectively 79%, 
70% and 81% of mild CNS duplication, versus the 23%  of wt sox3) 
and a lower amount of severe phenotypes (respectively 3%, 11% 
and 0% of severe CNS duplication versus the 55% of wt sox3 and 
3%, 15% and 12% of major disruption of neural tissue versus the 
20% of wt sox3). This suggests mild loss of Sox3 function. 
6) Microinjection of mut7 caused effects comparable to those of wt 
sox3, presenting 2% of embryos with normal phenotypes, 32% with 
mild CNS duplication, 59% with severe CNS duplication and 7% 
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with major neural tissue disruption. This suggests no loss of Sox3 
function. 
7) Finally, as expected, microinjection of mut12 did not affect the 
development of the nervous system as its over-expression caused 
normal phenotype in 100% of the embryos. 
In the second set of experiments UN and GFP-injection controls were 
repeated, as well as injections of mut12 and wt sox3, whose effects were 
compared to the effects of microinjecting mut1, mut8, mut9, mut10 and 
mut11 (Fig. 3.17 ,Table 3.5): 
1) Both UN embryos and embryos microinjected with GFP showed 
100% normal phenotypes; 
2) Microinjection of wt sox3 caused 100% severe CNS duplication 
phenotypes; 
3) Interestingly, embryos microinjected with mut1 presented mostly 
normal phenotypes (58%) in addition with 37% of mild CNS 
duplication, only 3% of severe CNS duplication and no major 
disruption of neural tissue; 
4) Microinjection of mut8 and mut9 did cause milder phenotypes as 
compared to wt sox3. These groups presented the majority of 
embryos with mild CNS duplication (respectively 63% and 75%), 
only a few with normal phenotypes for mut8 (9%) and none for 
mut9, in addition to 17% with severe CNS duplication in both mut8 
and mut9, and respectively 11% and 8% with major CNS 
disruption. 
5) Microinjection of mut10 caused mild CNS duplication in 15% of the 
embryos, severe CNS duplication in 36% of the embryos and major 
CNS disruption in 48% of the embryos. These last data are 
indicated in figure 3.17 and in Table 3.3 with a different colour 
(violet) than the other “major neural tissue disruption” data (red) 
as although they belonged to the same category (the embryos were, 
in most of the cases, not developed and the nervous tissue was 
completely disrupted), their appearance was distinctly different, 
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resembling the early bud stage, when neural plate forms. This topic 
is further discussed in Section 4.2. 
6) Microinjection of mut11 resulted in no normal phenotypes, mild 
CNS duplication in 32% of the embryos, severe CNS duplication in 
48% of the embryos and major CNS disruption in 20% of the 
embryos. 
7) Microinjection of mut12 confirmed the data obtained with the 
previous experiments, causing 100% normal phenotypes. 
The experiments described above showed that microinjection of Sox3 
deletion mutants had different effects in 24 hpf embryos compared to 
microinjection of wt Sox3. Therefore, the deletions did modify the function 
of the protein. The deletion of such large regions of the protein could have 
disrupted its functionality dramatically, and in this case the injections 
would have caused the same phenotypes in all the groups of injected 
embryos. However, the data presented above demonstrated that 
microinjection of different deletion mutants caused different phenotypes, 
showing that the deletion approach adopted was effective to identify 
different functions of Sox3.  
However, the analysis of the phenotypes that the embryos presented at 24 
hpf was insufficient to determine which were the different effects caused 
by each deletion, as many other regulatory pathways are involved in the 
formation of the neural tissue at this stage. Moreover, the functional 
redundancy showed by the other SoxB1 factors can interfere with the 
analysis at such a late stage of development (Okuda et al. 2006; Miyagi et 
al. 2009; Shih et al. 2010). For these reasons, in order to investigate how 
the deletions changed Sox3 activity, further experiments were carried out 
at earlier stage of development, when Sox3 is the only SoxB1 factor 
expressed and it is possible to analyse its function more directly.  
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Figure 3.14A “Normal” and “mild CNS duplication” phenotypes obtained through whole 
mount in situ hybridization for ncad on 24 hpf embryos uninjected or injected with GFP
or/and wt/mut sox3. Each embryo is shown from the lateral side, from the dorsal side and 
from the animal pole side. Black arrows indicate localised duplications or abnormalities of the 
CNS. 
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Figure 3.14B “Severe CNS duplication” and “major disruption of the neural tissue” 
phenotypes obtained through whole mount in situ hybridization for ncad on 24 hpf 
embryos uninjected or injected with GFP or/and wt/mut sox3. Each of the embryos with 
severe CNS duplication is shown is from the lateral side, from the dorsal side and from the 
animal pole side. Each of the embryos with major disruption of the neural tissue is shown from 
the dorsal view and from the animal pole. 
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Figure 3.15 Embryos 24 hpf that were microinjected with mut10
presented a unique phenotype that involved major disruption of 
the neural tissue but was different from the phenotypes caused 
by injection of the other constructs. The top panel shows a normal 
24 hpf embryo (A, B, C), the following four panels show different 
embryos that were microinjected with mut10 (pictures from D to O) 
and the last panel shows an embryo that was injected with wt sox3
and was characterised by major disruption of the neural tissue (P, Q). 
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Figure 3.16 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar numbered 
accordingly to the name of the mutant.  The chart shows the results of whole mount in situ 
hybridisation for ncad performed on 24 hpf embryos uninjected (UN), injected with GFP 
(GFP), co-injected with GFP and wt sox3  or co-injected with GFP and mut2, mut3, mut4, mut5, 
mut6, mut7 or  mut12. 
  
Total number of 
embryos 
43 38 66 70 35 29 27 26 41 26 
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Table 3.4 Numbers of 24 hpf embryos analysed with whole mount in situ hybridisation for 
ncad in the second set of experiments. The data shown correspond to the percentages shown in 
figure 3.16. 
  
  
normal 
mild CNS 
duplication 
severe CNS 
duplication 
major 
disruption of 
neural tissue 
tot 
UN 43 0 0 0 43 
GFP 38 0 0 0 38 
wtSox3 2 15 36 13 66 
Mut2 15 47 7 1 70 
Mut3 0 7 20 8 35 
Mut4 4 23 1 1 29 
Mut5 1 19 3 4 27 
Mut6 2 21 0 3 26 
Mut7 1 13 24 3 41 
Mut12 26 0 0 0 26 
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Figure 3.17 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar numbered 
accordingly to the name of the mutant.  The chart shows the results of whole mount in situ 
hybridisation for ncad performed on 24 hpf embryos respectively uninjected (UN)or 
injected with GFP (GFP)or co-injected with GFP and wt sox3 or Mut1, Mut8, Mut9, Mut10, 
Mut11,  Mut12. The data shown in purple indicates the unique phenotype presented by embryos 
injected with mut10 (Fig. 3.15). 
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Total number of 
embryos 
35 35 12 38 35 52 33 25 44 
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Table 3.5 Numbers of 24 hpf embryos analysed with whole mount in situ hybridisation for 
ncad in the first set of experiments. The data shown correspond to the percentages shown in 
figure 3.17. The data shown in purple indicates the unique phenotype presented by embryos 
injected with mut10 (Fig. 3.15). 
  
  
normal 
mild CNS 
duplication 
severe CNS 
duplication 
major 
disruption of 
neural tissue 
tot 
UN 35 0 0 0 35 
GFP 35 0 0 0 35 
wtSox3 0 0 12 0 12 
1 22 14 2 0 38 
8 3 22 6 4 35 
9 0 39 9 4 52 
10 0 5 12 16 33 
11 0 8 12 5 25 
12 44 0 0 0 44 
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3.5. Effects of the Over-expression of Sox3 Deletion 
Mutants on Organizer Formation 
3.5.1. Introduction 
In order to get deeper insight into the relation between structure and 
function of Sox3, and in particular to dissect how deletions affected Sox3 
functions, the following experiments focused on the early stages of the 
development, where the regulatory mechanisms are better known and the 
phenotypes are likely to be a more direct result of the over-expression of 
the protein. In particular, we analysed the function of Sox3 in the context 
of the organizer formation, at 4.5 hpf. Therefore, 1-4 cell stage embryos 
were microinjected with CAP RNA, incubated for 4.5 hpf, then fixed and 
subsequently analysed with whole mount in situ hybridization. In situ 
hybridization was performed in order to detect the expression of the 
organizer markers bozozok and goosecoid; 
 bozozok (also known as dharma) is a homeobox gene that in 
zebrafish is essential for the formation and/or the induction of the 
Nieuwkoop center and, therefore, for the subsequent formation of 
the organizer (Ryu et al. 2001). In the developing zebrafish embryo, 
prior to axis formation, there is accumulation of β-catenin in the 
nuclei situated in that part of the yolk syncytial layer that lies 
beneath the cells that will later become the organizer (Schneider et 
al. 1996). In the late blastula nuclear localization of β-catenin 
activates organizer genes such as bozozok (boz) and squint. This 
homeodomain protein is a transcription factor that works in many 
different ways: firstly, it can repress BMP and wnt genes, which 
promote ventralization, secondly it suppresses the inhibitor of 
transcription vega1, allowing the activation of the organizer genes, 
and thirdly it acts with Squint in the activation of goosecoid (gsc), 
noggin and dickkopf (Gritsman et al. 2000; Kawahara et al. 2000; 
Solnica-Krezel and Driever 2001).  
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 Goosecoid is a homeobox gene and it is one of the earliest markers 
expressed during organizer formation (Cho et al. 1991; Stachel et 
al. 1993; Toyama et al. 1995). Gsc blocks the Bone Morphogenetic 
Proteins (BMPs) and Wnts allowing the formation of the neural 
ectoderm and the dorsal mesoderm (De Roberts et al. 1992; Yasuo 
and Lemaire 2001).  
Ectopic expression of wt sox3 obtained through capped RNA 
microinjection has been shown to repress organizer formation, as 
demonstrated in previous studies from our laboratory (Shih et al. 2010; 
Kuo et al. 2013). In the following experiments the effects caused by ectopic 
over-expression of sox3 deletion mutants were investigated through the 
analysis of the expression of boz and gsc in vivo. 
3.5.2. Ectopic Over-expression of wt zfSox3 Represses 
Organizer Markers 
In order to optimise the experimental conditions for the comparison 
between the effects of ectopic expression of wt Sox3 and its deletion 
mutants, zebrafish embryos uninjected (UN) or injected with wt Sox3 RNA 
were incubated until the sphere stage and fixed with 4% 
paraformaldehyde. The embryos were then analysed through whole 
mount in situ hybridization in order to test the efficiency of newly 
synthetized DIG-labelled oligo-probes for bozozok and goosecoid. 
Moreover, the experiment was aimed to test whether that the 
experimental conditions allowed the visualisation of a clear signal that 
would have subsequently be essential for comparing with wtSox3 over-
expression. All the uninjected embryos showed a strong purple staining 
localised in the region of the organizer for both bozozok and goosecoid 
probes (Fig. 3.18). The signal was strong enough to see clearly the 
difference between the uninjected embryos and the embryos injected with 
wt Sox3 (Fig. 3.19), and presumably to determine whether the deletion 
mutant constructs would have caused changes in the signal compared to 
the wt protein. For this reason the subsequent experiments were 
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performed under the same experimental conditions: microinjection of 50 
pg of RNA, incubation of the embryos until sphere stage and whole mount 
in situ hybridization for boz or gsc. 
 
Figure 3.18 Whole mount in situ hybridization of sphere stage embryos with oligo-
probes for bozozok (A, B, C, D) and goosecoid (E, F, G, H). Each embryo is shown from the 
lateral view (A, C, E, G) and from the animal pole view (B, D, F, H). The dark staining 
developed in the organiser region, which corresponds to the region where boz and gsc are 
expressed, is localised and clearily visible. 
Figure 3.19 Sphere stage embryos uninjected (A) and microinjected with wt sox3 (B) 
analysed through whole mount in situ hybridization for boz. While the majority of the embryos 
shown in picture A present a strong signal, the embryos shown in picture B present just faint or 
totally absent signal. 
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3.5.3. Expression of bozozok in Embryos Microinjected 
with Sox3 Deletion Mutants  
In the following experiments zebrafish embryos at 1-4 cell stage were 
microinjected with RNA encoding GFP, wt Sox3 or each of deletion mutant 
Sox3 proteins, incubated at 28˚C until they reached Sphere Stage and 
analysed with whole mount in situ hybridization using bozozok DIG-
labelled riboprobes. The same experiment was performed on uninjected 
embryos as negative control. The embryos injected with only GFP were 
used as negative control to assess that the injection procedure did not 
affect the analysis. All the other groups of embryos were co-injected with 
the desired sox3 construct together with GFP: this allowed verification that 
the injections were effective by visualising the fluorescence of the 
expressed GFP under UV light after the incubation of the embryos. As for 
the analysis of 24 hpf embryos, two separate sets of experiments were 
performed to analyse all the constructs; each one of the experiments was 
performed together with the uninjected (UN) and the GFP (GFP) controls, 
as well as the wt Sox3 (wtSox3).  
Normal expression levels of boz were expected in uninjected and GFP-
injected embryos, while lower expression was expected in wt Sox3-
injected embryos. These expectations were indeed confirmed in both the 
experiments, where the resulting phenotypes were categorised in three 
groups: normal expression, when the staining developed was dark purple 
and clearly visible especially from the lateral view (Fig. 3.20 E, F), partial 
repression, when the staining was lighter than the normal phenotype from 
the lateral view and barely visible from any other side of the embryo (Fig. 
3.20 C, D), and total repression, where the staining was not detectable 
from any side of the embryo, which looked completely white (Fig. 3.20 A, 
B). Moreover, an additional phenotype (ectopic expression of boz) was 
identified only in embryos co-injected with GFP and mut1 (Fig. 3.21).  
In the first set of experiments boz expression levels found in UN, GFP-
injected and wt sox3-injected embryos were compared to the expression 
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caused by microinjections of mut2, mut3, mut4, mut5, mut6, mut7 and 
mut12 (Fig. 3.22, Table 3.6). The results were as follows: 
1) The data confirmed that ectopic expression of wt Sox3 causes a 
decrease in boz expression levels when compared to the controls, 
as 98% of UN embryos showed normal expression of boz as well as 
94% of GFP embryos, while only 20% of wt sox3-injected embryos 
showed normal expression and the other 80% showed partial 
repression (40%) or total repression (40%).  
2) The comparison between injection of wt sox3 and injections of Sox3 
deletion mutants showed that the level of repression caused by 
mut2, mut3 and mut4 is lower than the wt sox3 as the percentages 
of normal embryos are higher, the percentages of partial repression 
comparable, and the percentages of total repression are lower. 
However, mut2, mut3 and mut4 did show a repressive effect on boz 
expression as demonstrated by the comparison with UN and GFP 
controls.  
3) Conversely, it appeared that injections of mut5 and mut6 caused a 
substantially milder repressive effect on boz expression, showing 
almost as many normal embryos as the controls, low percentages of 
partial repression (respectively 8% and 16%) and no total 
repression.  
4) Microinjection of mut7 resulted in a percentage of normal embryos 
comparable to mut2, mut3 and mut4, which is lower than UN and 
GFP, but higher than wt sox3, however there was no embryos 
showing partial repression and 42% showing total repression.  
5) As expected, injection of mut12 caused a percentage of normal 
embryos comparable to the UN and GPF (88% compared to 98% 
and 94%) together with a few embryos showing partial repression 
(13%).  
In the second set of experiments the UN and GFP controls were repeated, 
as well as the mut12 control, which was expected to have lost Sox3 
repressor function. In these experiments the levels of expression of boz 
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were compared between the controls, embryos microinjected with GFP 
and wt sox3 and embryos injected with GFP and mut1, mut8, mut9, mut10, 
mut11 and mut12 (Fig. 3.23, Table 3.7). The results were as follows: 
1) Both UN embryos and embryos injected with GFP showed 100% 
normal phenotypes, while embryos injected with wt sox3 showed 
only 11% normal phenotypes and the other 89% of embryos 
caused partial repression (49%) or total repression (40%). This is 
consistent with the results of the first experiment.  
2) Also the effects caused by injecting mut12 were consistent with 
previous data as comparable to the UN and GFP controls, showing 
97% normal embryos and 3% partial repression.  
3) Interestingly, injection of mut1 caused a unique phenotype in 35% 
of the embryos. This phenotype was not found in any other sample 
and was characterised by ectopic expression of boz outside the 
organizer region (Fig. 3.20). Moreover, the remaining 65% of 
mut1-injected embryos showed a normal phenotype a none 
showed repression of boz.  
4) Microinjections of mut8, mut9 and mut10 had milder repressive 
effects than microinjections of wt sox3, showing higher 
percentages of normal embryos and lower percentages of embryos 
showing partial and total repression of boz.  
5) Microinjection of mut11 caused a lower repression of boz 
compared to wt Sox3: 86% of the embryos had a normal 
phenotype, while only 8% partial repression and 6% total 
repression.  
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Figure 3.20 Pictures representing the three categories of 
phenotypes obtained through whole mount in situ
hybridization for boz on sphere stage embryos uninjected or 
injected with GFP or/and wt/mut sox3. The phenotypes include: 
total repression of boz (A, B), partial repression of boz (C, D) and 
normal expression of boz (E, F). 
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Figure 3.21 Microinjection of mut1 variable ectopic expression of 
bozozok in sphere stage embryos. Each panel shows the same embryo 
viewed from different sides. The phenotype of these embryos is 
characterised by variable ectopic expression of boz outside the organizer 
region. 
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Figure 3.22 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar numbered 
accordingly to the name of the mutant.  The chart shows the results of whole mount in situ 
hybridisation for boz performed on Sphere Stage embryos respectively uninjected (UN)or 
injected with GFP (GFP)or co-injected with GFP and wt sox3 or mut2, mut3, mut4, mut5, mut6, 
mut7,  mut12. 
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Figure 3.23 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar numbered 
accordingly to the name of the mutant.  The chart shows the results of whole mount in situ
hybridisation for boz performed on sphere stage embryos respectively uninjected (UN)or 
injected with GFP (GFP)or co-injected with GFP and wt sox3 or mut1, mut8, mut9, mut10, 
mut11, mut12. 
Total number of 
embryos 
35 34 35 34 34 34 35 36 35 
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Table 3.6 Numbers of Sphere Stage embryos analysed with whole mount in situ 
hybridisation for boz in the first set of experiments. The data shown correspond to the 
percentages shown in figure 3.22. 
 
 
 
Table 3.7 Numbers of Sphere Stage embryos analysed with whole mount in situ 
hybridisation for boz in the second set of experiments. The data shown correspond to the 
percentages shown in figure 3.23. 
  
  
normal 
partial 
repression 
total 
repression 
total 
UN 50 0 1 51 
GFP 30 1 1 32 
wtSox3 7 14 14 35 
Mut2 18 13 2 33 
Mut3 19 10 4 33 
Mut4 30 15 4 49 
Mut5 37 3 0 40 
Mut6 27 5 0 32 
Mut7 15 0 11 26 
Mut12 35 5 0 40 
  
ectopic normal 
partial 
repression 
total 
repression 
total 
UN 0 35 0 0 35 
GFP 0 34 0 0 34 
wtSox3 0 4 17 14 35 
Mut1 12 22 0 0 34 
Mut8 0 26 4 4 34 
Mut9 0 19 7 8 34 
Mut10 0 24 7 4 35 
Mut11 0 31 3 2 36 
Mut12 0 34 0 1 35 
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3.5.4. Expression of goosecoid in Embryos Microinjected 
with Sox3 Deletion Mutants 
In order to get a deeper insight into the effects of the different Sox3 
mutant constructs on the formation of the organizer, the in situ 
hybridization analysis was repeated with the organizer marker goosecoid 
(gsc). Also in this case the experiments were performed in two separate 
sets, in order to test the effects of the over-expression of all the twelve 
Sox3 deletion constructs compared to the wt Sox3. The phenotypes 
resulting from the experiments were categorised as normal, when the 
colour developed by in situ hybridization was dark purple and clearly 
visible in the organizer region (Fig. 2.24 G, H, I) partial repression, when 
the signal was barely visible (Fig. 2.24 D, E, F) and total repression, when 
the embryo appeared completely white (Fig. 2.24 A, B, C). 
In the first set of experiments uninjected embryos (UN), embryos injected 
only with GFP (GFP) and embryos injected with GFP and wt Sox3 (wtSox3) 
were compared to embryos injected with GFP and mut2, mut3, mut4, mut5, 
mut6, mut7 and mut12 (Fig. 3.25, Table 3.8). The results were as follows: 
1) All UN embryos showed the normal phenotype (100%).  
2) The 68% of the embryos injected with GFP showed normal 
expression of gsc and the remaining 32% partial repression. 
3) As expected, over-expression of wt sox3 resulted in a strong 
repression of gsc as 41% of the embryos showed partial repression 
phenotype and 59% total repression. 
4) Also injections of mut2 and mut3 had a comparably strong 
repressive effect, as only 3% of the embryos were normal after 
injection of mut2 a none after injection of mut3. Moreover, 
microinjection of mut2 and mut3 caused partial repression in 
respectively 72% and 43% of embryos and total repression in 25% 
and 57% of embryos. 
5) Microinjection of mut4 seemed to repress gsc slightly less than 
microinjection of wt sox3: 34% of the embryos injected with mut4 
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were found to be normal, but still 34% showed partial repression 
and 31% total repression. 
6) Injection of mut5, as well as mut7, repressed gsc with the same 
extent of wt sox3, having respectively 26% and 39% of partial 
repression, 74% and 61% of total repression and no normal 
embryos. 
7) On the other hand, injection of mut6 caused 48% normal 
phenotype, which seemed to be quite comparable to the 68% found 
for the GFP-injected embryos, 43% of partial repression and only 
9% of total repression. 
8) Surprisingly, injections of mut12 did not cause any normal 
phenotype, but it caused partial repression in 67% of the embryos 
and total repression in 33% of the embryos. 
In the second set of experiments the UN and GFP experimental controls 
were repeated, as well as mut12 and wt sox3 for the same reasons 
previously explained in the context of bozozok expression analysis 
(Chapter 3.5.3). In these experiments the expression on gsc was compared 
between embryos uninjected, or microinjected only with GFP or 
microinjected with GFP and wt sox3, or mut1, mut8, mut9, mut10, mut11, 
mut12 (Fig. 3.26, Table3.9). The results were as follows: 
1) UN and GFP showed respectively 88% and 89% of normal 
phenotype, in addition with 12% and 11% of partial repression; 
2) Microinjection of wt sox3 caused 57% normal phenotype, 17%  
partial repression and 26%  total repression; 
3) The effects caused by injection of mut1 were comparable to the UN 
and GFP controls, as it seemed not to repress gsc expression. In 
fact, 89% of embryos injected with mut1 presented normal 
phenotype and 11% partial repression. 
4) Injections of mut8, mut9 and mut10 caused a milder repression of 
gsc compared to wt sox3. In fact, they caused higher percentage of 
normal phenotypes compared to wt sox3, even though they still 
showed repression of gsc. 
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5) Interestingly, injection of mut11 seemed not to cause repression of 
gsc, as it resulted in a normal phenotype in 94% of the embryos 
(versus the 57% of wt sox3 and the 88% and 89% of UN and GFP) 
and partial repression in only the 6% of the embryos, which is 
comparable to the 12% and 11% found for the UN and GFP 
controls. 
6) Injection of Mut12 did not presented any repressive effect as gsc 
was normally expressed in 100% of the embryos. 
It is quite evident that the results obtained with the two set of 
experiments had some variability. In fact, in the first set of 
experiments UN embryos showed 100% normal phenotype, while in 
the second set 88% showed normal phenotype and 12% partial 
repression (Fig. 3.25 and Fig. 3.26). Also GFP-injected embryos 
seemed to present variability of gsc expression between the two sets 
of experiments, showing 32% of embryos with partial repression 
phenotype in the first set, while 11% in the second one (Fig. 3.25 and 
Fig. 3.26). However, although it seemed to be an overlapping between 
the normal phenotype and the partial repression phenotype, there 
were no embryos presenting total repression in UN or GFP controls, 
therefore the experiments were considered reliable. The reasons that 
could explain the variability of gsc expression are presented and 
discussed in Section 4.3.2.    
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Figure 3.24 Pictures representing the three categories of phenotypes obtained 
through whole mount in situ hybridization for gsc on sphere stage embryos 
uninjected or injected with GFP or/and wt/mut sox3. The phenotypes include: 
total repression of gsc (A, B, C), partial repression of gsc (D, E, F) and normal 
expression of gsc (G, H, I). 
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Figure 3.25 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar numbered 
accordingly to the name of the mutant.  The chart shows the results of whole mount in situ
hybridisation for gsc performed on sphere stage embryos respectively uninjected (UN)or 
injected with GFP (GFP)or co-injected with GFP and wt sox3 or mut2, mut3, mut4, mut5, mut6, 
mut7,  mut12. 
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Figure 3.26 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar numbered 
accordingly to the name of the mutant.  The chart shows the results of whole mount in situ
hybridisation for gsc performed on Sphere Stage embryos respectively uninjected (UN)or 
injected with GFP (GFP)or co-injected with GFP and wt sox3 or mut1, mut8, mut9, mut10, 
mut11, mut12. 
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Table 3.8 Numbers of sphere stage embryos analysed with whole mount in situ hybridisation 
for gsc in the second set of experiments. The data shown correspond to the percentages shown in 
figure 3.25. 
  normal partial repression total repression total 
UN 34 0 0 34 
GFP 21 10 6 37 
wtSox3 0 13 19 32 
Mut2 1 26 9 36 
Mut3 0 19 25 44 
Mut4 10 10 9 29 
Mut5 0 11 32 43 
Mut6 11 10 2 23 
Mut7 0 12 19 31 
Mut12 0 30 15 45 
Table 3.9 Numbers of sphere stage embryos analysed with whole mount in situ hybridisation 
for gsc in the first set of experiments. The data shown correspond to the percentages shown in 
figure 3.26. 
  normal partial repression total repression total 
UN 30 4 0 34 
GFP 31 4 0 35 
wtSox3 20 6 9 35 
Mut1 32 4 0 36 
Mut8 27 5 3 35 
Mut9 24 2 9 35 
Mut10 24 4 9 37 
Mut11 32 2 0 34 
Mut12 35 0 0 35 
107 
 
3.6. Transcriptional Activation Function of wt and 
Deletion Mutant Sox3 Proteins 
Luciferase reporter assay analysis was performed in order to determine 
whether the deletions in Sox3 constructs modified the ability of wt Sox3 to 
activate the transcription of a target gene. Zebrafish 1-4 cell stage embryos 
were incubated uninjected (UN control), or after co-injection with  sox3 
(wt or deletion mutants) capped RNA (50pg) and GFP capped RNA (50pg) 
together with a plasmid containing three Sox3 binding sites upstream the 
Firefly luciferase gene (pGL3-3XSX, 5 pg, Appendix 7.4). The experiment 
was also performed on a control group of embryos that were co-injected 
with GFP RNA and pGL3-3XSX plasmid, as the endogenous Sox3 was also 
expected to cause expression of the luciferase.  
The co-injection of embryos with GFP together with the sox3 constructs 
allowed the selection of the embryos that showed similar levels of 
expression of GFP. Microinjection of RNA does not result in the protein 
being uniformly expressed throughout the entire embryo, it can be quite 
variable. This can be due to different reasons, including the stage when the 
embryo is injected and the position of the needle when injecting. In other 
words, since the manual component of this technique is relevant, it cannot 
be perfectly reproducible. However, the injection of GFP allowed 
visualisation of the expression pattern of the injected construct under UV 
light after the incubation of the embryos until sphere stage (Fig. 3.27). 
Therefore, only embryos that showed similar and diffuse expression of 
GFP were selected and used for the analysis. 
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Figure 3.27 Sphere Stage embryos that were previously co-
injected at 1-4 cell stage with GFP RNA (50 pg), wt Sox3 RNA (50 
pg) and pGL3-3XSX plasmid (5 pg) and then incubated for 
approximately 4 ½ hours. The embryos are shown under UV light to 
visualise expression of GFP, which can vary due to the microinjection 
procedure. This is clearly visible in fig.D, where the left embryo shows 
GFP expression in a restricted area, while the right embryo shows a 
diffused expression of GFP. Highly expressed GFP appears as blue due 
to the printing of the image. 
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The aim of the study was to investigate the activity of Sox3 as a 
transcriptional activator and repressor. The selection of the constructs to 
be analysed with the Luficerase Reporter Assay was based on the data 
obtained with the previous experiments, which showed the repression 
function of Sox3. For this reason, the experiment was performed on the 
experimental groups shown in Table 3.10. For each experimental group 
the experiment was repeated three times on three different groups of 
embryos in order to normalise the results and check that they had not 
been affected by technical errors.  
The results of the experiments are represented in Fig. 3.28-3.29 and Table 
3.11. As expected, the UN control showed a low level of luminescence (the 
mean of raw readings is 23), which was due to background luminescence. 
As shown in Fig. 3.28, Fig. 3.29 and Table 3.11, the reporter gene was 
activated in the GFP co-injected embryos, presumably due to the presence 
of endogenous Sox3. The reading for wtSox3-injected embryos presented 
a two-fold increase compared to GFP. Mut1 activated the luciferase gene 
with a two-fold increase compared to wtSox3, while Mut2 did not activate 
it. Mut5 showed a remarkably strong activation effect, which was 
approximately tenfold increase compared to wtSox3. The reading for Mut6 
is comparable to wtSox3. Mut7 failed to activate the reporter, while Mut10 
did show an activation remarkably lower than the GFP control.  Mut11 
strongly activated the reporter gene compared to wtSox3. Finally, as 
expected, Mut12 failed to activate the reporter gene, but the reading was 
even lower than the GFP control. 
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Name 
Microinjected 
constructs 
Reasons 
UN - 
Negative control  
GFP 
• GFP RNA  
• pGL3-3XSX 
Control for the activation of the reporter gene 
by endogenous Sox3 
wtSox3 
• wt Sox3 RNA 
• GFP RNA 
• pGL3-3XSX 
Necessary for the comparison with the 
deletion mutants 
Mut1 
• mut1 RNA 
• GFP RNA 
• pGL3-3XSX 
Caused ectopic expression of boz and did not 
repress gsc expression. 
Mut2 
• mut2 RNA 
• GFP RNA 
• pGL3-3XSX 
The deleted region contains highly conserved 
amino acid patterns and is located between 
the HMG domain and the region deleted in 
Mut5 and Mut6. 
Mut5 
• mut5 RNA 
• GFP RNA 
• pGL3-3XSX 
Did not caused repression of boz. 
Mut6 
• mut6 RNA 
• GFP RNA 
• pGL3-3XSX 
Did not caused repression of boz and gsc. 
Mut7 
• mut7 RNA 
• GFP RNA 
• pGL3-3XSX 
The deleted region contains the SUMOylation 
site (Chapter 1.3.2). The inability to be 
SUMOylated could affect the activity of Sox3 
as transcriptional activator. 
Mut10 
• mut10 RNA 
• GFP RNA 
• pGL3-3XSX 
Caused unique and distinctive phenotypes 24 
hpf embryos. 
Mut11 
• mut11 RNA 
• GFP RNA 
• pGL3-3XSX 
The deleted region is the N-terminal region of 
the protein, which is thought not to be 
involved in the activation function. 
Mut12 
• mut12 RNA 
• GFP RNA 
• pGL3-3XSX 
Good control as it contains only the N-
terminal region and the DNA binding domain; 
it is expected not to be able to activate the 
reporter gene. 
Table 3.10 Experimental groups chosen for performing Luciferase Reporter Assay, 
constructs injected in the embryos of each group and reasons why each construct was 
chosen. 
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Figure 3.28 The top of the figure shows a schematic representation of the deletion 
constructs: the regions deleted in each of the mutants is represented as a red bar 
numbered accordingly to the name of the mutant. The chart represents the mean 
values of the three readings of the Luciferase Reporter Assay made for each of the 
experimental groups of embryos. The groups included: uninjected embryos (UN), 
embryos injected with GFP only (GFP), and embryos co-injected with GFP and wt sox3 or 
mut1, mut2, mut5, mut6, mut7, mut10, mut11, mut12. The error bars were built using the 
standard deviation of the values (Table 3.10).  
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Column1 1 2 3 mean st. dev. 
UN 30 17 22 23 5.35 
GFP  256 213 247 239 18.52 
wtSox3 523 455 430 469 39.30 
Mut1 838 803 794 812 18.98 
Mut2 126 123 138 129 6.48 
Mut5 5513 5302 5016 5277 203.67 
Mut6 523 537 573 544 21.06 
Mut7 112 135 87 111 19.60 
Mut10 39 64 78 60 16.13 
Mut11 2063 2181 1762 2002 176.41 
Mut12 103 89 86 93 7.41 
Table 3.11 Raw data of the Luciferase Reporter Assay made on sphere stage embryos 
uninjected (UN), or microinjected with GFP only (GFP), or co-injected with GFP and wt/mut 
sox3. The first three columns of data correspond to the reading of three different groups of embryos 
(1, 2, 3), the fourth column contain the mean of the readings and the last column correspond to the 
standard deviation (st. dev.). 
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Figure 3.29 The chart represents the values of the three readings (1, 2, 3) of the 
Luciferase Reporter Assay made for each of the experimental groups of embryos. The 
groups included: uninjected embryos (UN), embryos injected with GFP only (GFP), and 
embryos co-injected with GFP and wt/mut sox3. 
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4. Discussion 
4.1. Deletion Cloning and Expression of Mutant 
Proteins in Zebrafish Allowed Functional 
Screening of the Entire Sequence of Sox3  
The design of the deletions in this study was made entirely on the basis of 
the pattern of conservation of Sox3 amino acids sequence between 
different species. This was made without considering any other 
information known (or presumptive) about the protein, such as post-
transcriptional modifications (for example SUMOylation or 
phosphorylation) or presumptive localisation of functional domains (for 
example the C-terminal region is thought to contain a trans-activation 
domain as do the other SoxB1 factors). The reason of this approach was to 
analyse the entire protein without preconception, so that the results 
obtained could have confirmed or dispute previous evidence. 
Furthermore, this approach could have given new clues onto the 
mechanisms of function of Sox3, thus providing new starting points for 
subsequent studies that could focus on more restricted regions of the 
protein.   
The design of many different deletions to be realised in the same gene led 
to problems in the cloning experiments because the efficiency of the 
cloning proved to be highly variable between different mutants. For this 
reason the design of a high efficiency cloning strategy was a key step for 
this study: a strategy that worked for creating all the clones allowed a 
more reliable comparison of their effects and, on the other hand, also a 
faster way to obtain all the constructs. In fact, the design of different 
approaches for different constructs would have added variability in the 
experiments and would have also required more time for the development 
and realisation. Moreover, an important feature of the cloning strategy 
that was developed is that it enabled the generation of large deletions and 
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the insertion of a diagnostic restriction site by inserting in the final protein 
just one or two additional amino acids (alanine and/or glycine).  
Since the design of the deletion did not take into account any other factor 
than the amino acids sequence, the obtained constructs could be missing 
regions necessary for the protein expression or regions that would have 
radically modified the levels of expression. The results of Western Blot 
analysis confirmed that the expression of all the mutant proteins was not 
affected by the mutation at sphere stage, and that the levels of expression 
were similar for all the constructs, including the wt.   
Therefore, the results obtained with the cloning experiments and with the 
Western Blot built the basis for all the subsequent experiments, which 
were based on the functional comparison between the different constructs 
obtained.  
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4.2. Analysis of the CNS at 24hpf Highlighted 
Differing Functions of the Sox3 Deletion 
Mutants 
  Each of the Sox3 mutant constructs contained a deletion of about 20 
amino acids, which is quite a large region considering the full-length 
protein is only 300 amino acids long. Therefore, such big deletions could 
have just caused disruption of the three-dimensional integrity of the 
protein, resulting in complete loss of function. In this case the over-
expression of the constructs would not have caused changes in the 
phenotypes of 24 hpf embryos, or the resulting phenotypes would have all 
been similar, as the mutant Sox3 proteins would have just been disrupted 
and not functioning, no matter where the different deletions were 
localised. However, the results of the experiments conducted on 24 hpf 
embryos clearly showed that different deletions caused different effects, 
especially in the cases of Mut1, Mut10 and Mut12. 
The results presented in Chapter 3.4 demonstrated that the over-
expression of wt Sox3 caused severe duplications of the CNS in the 
majority of the embryos, while most of the mutants showed milder effects. 
This means that by deleting the corresponding regions of Sox3, the 
function of the protein has been changed.  
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4.3. The Deletion of Different Regions of Sox3 
Caused Different Effects on the Protein’s 
Repressor and Activator Functions 
The analysis of the effects that microinjection of Sox3 deletion mutants 
had in 24 hpf embryos was followed by the analysis of their effects at the 
sphere stage. This analysis was more direct, as it was possible to 
investigate whether a known function of Sox3 (repression of organizer 
formation) was changed at a stage when no other SoxB1 proteins are 
known to be expressed, and therefore no functional redundancy should be 
present. Over-expression of different Sox3 deletion mutants caused 
different changes in the expression of the organizer markers compared to 
the wt protein and allowed us to get a better understanding of how the 
different deletions affected the repressor function of Sox3.  
While the data obtained through the analysis of the expression of bozozok 
were very consistent between the two sets of experiments performed, the 
results obtained on the transcriptional regulation of goosecoid (Section 
3.5.4) did show a difference between the two sets of experiments 
performed. In fact, if comparing the two sets of results, it may seems that 
the repressive effects were generally stronger in the first set, and milder in 
the second set, which showed higher percentages of normal phenotypes in 
all the samples analysed. However, there are different reasons that could 
explain this phenomenon. Firstly, the two sets of experiments correspond 
to two different in situ hybridisation experiments, which means that the 
difference can be due to the technical repetition: for example, a change in 
the temperature during the phases of hybridisation, or longer time in the 
manipulation of the samples can cause a difference in the hybridization of 
the probes to the target transcripts. Another factor that can cause 
variations between different replicas of this technique is the different 
solutions that are used, and that can be slightly different. However, both 
the sets of experiments were performed together with two different 
control groups each (UN and GFP), and the consistency of these controls 
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allows to trust the results obtained. In fact, in both the sets of experiments 
the control showed percentages of normal phenotypes higher than the wt 
Sox3, which means that the repressive effect that Sox3 had on gsc 
expression is visible and consistent in both the sets of experiments, even 
though it may seem more severe in the first data compared to the second 
ones. For the reasons just explained it is not correct, however, to compare 
the results obtained with different experiments without considering the 
results obtained for the controls: in particular, the GFP control seemed to 
be more severely affected by injection in the first set of experiments, but it 
seemed that the decrease in the development of the purple signal is due to 
the experimental technique rather than a more severe repressive effect on 
gcs expression. Moreover, as discussed below, the data obtained are also 
consistent with the results on the expression of bozozok. In addition, in 
interpretation of the results obtained by the analysis of the expression of 
goosecoid must be taken in count that the repressive effect that Sox3 has 
on gsc is not as direct has the one that it has on boz. In fact, it had been 
shown that Sox3 represses gsc through at least two mechanisms: one is 
direct repression, the other is mediated by the repression of boz, which 
normally activates gsc (Fig. 4.1), (Shih et al. 2010). The reason why in this 
project it was chosen to study the expression of gsc, together with boz 
(instead of squint for example), was to observe the effects that Sox3 
deletion mutants would have caused on target genes located at different 
steps of the signalling pathway and repressed through different 
mechanisms by Sox3.  
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The luciferase reporter assay allowed the analysis of how the deletions 
changed the activator function of Sox3. As explained in the Introduction 
(Chapter 1.6), the main aim of this study was to identify regions of Sox3 
that are involved in its ability to function both as a transcriptional 
repressor and a transcriptional activator with context-dependency. While 
the results obtained through the analysis of the effects that the different 
deletion mutants have on the formation of the organizer provided 
information about the regions of Sox3 that are involved in its repression 
function, the experiments performed in the Luciferase Assay were meant 
to provide information about Sox3 activation function. In fact, this assay 
measures the ability of the protein to activate target genes. However, 
because Sox3 is both an activator and a repressor, it is uncertain whether 
an increase in luciferase activity is due to an increase in the activator 
function of Sox3, or to a decrease in its repressor function. Since all the 
mutant Sox3 constructs created in this study lacked specific regions of the 
protein, we can presume that if a mutant caused an increase in the 
luciferase activity, than the deleted region might contain residues that are 
important for Sox3 repression function. On the other hand, a decrease in 
the luciferase activity would indicate that a region important for Sox3 
activation function is missing. Alternatively, it is also possible that the 
decrease in the luciferase activity is due to a dominant-negative 
interaction of the mutant protein on the endogenous Sox3, which would 
no longer be able to activate the reporter gene with the same extent.    
Figure 4.1 Model of the transcriptional repression role of Sox3 during the formation of the 
organizer. Sox3 represses Gsc both directly (1) and through the repression of Boz (2). Picture 
adapted from Shih et al. (2010). 
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In the following paragraphs the deletion mutants that generated 
consistent data in the analysis of 24 hpf embryos, in the analysis of the 
expression of organizer markers and in the luciferase reporter assay are 
discussed together with the hypotheses that could explain their effects. 
The other deletion mutants (Mut2, Mut3, Mut4, Mut8 and Mut9) did 
generally show milder repressive effects on the organizer marker genes if 
compared to wt Sox3, but the data were not sufficient to formulate more 
specific hypothesis for explaining these effects. Only Mut2 was also 
analysed through Luciferase Reporter Assay and it activated the reporter 
gene less than the GFP control. This could mean that Mut2 lost the 
repressor function and also that it acted as a dominant-negative on 
endogenous Sox3. In order to explain these effects more experiments are 
needed. Moreover, these data also suggest that it could be interesting to 
conduct further analysis also on Mut3, Mut4, Mut8 and Mut9.  
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4.3.1. Mutant 1 
 
Figure 4.2 Schematic representation of sox3 showing the region deleted in Mut1. 
The region missing from Mutant 1 is located imediately C-terminal to the 
HMG domain (Fig. 4.2). Microinjection of mut1 affected the development of 
the CNS in 24 hpf embryos substantially less than microinjection of wt 
Sox3. The over-expression of Mut1 caused a unique pattern of expression 
of bozozok: it was found that this organizer marker was expressed in the 
region of the organizer but also ectopically in other regions (Fig. 4.3B). 
This particular phenotype has already been seen in other experiments, 
where dominant negative forms of Sox3 were over-expressed in zebrafish 
embryos (Fig. 4.3A), (Shih et al. 2010). Shih et al. tested the ability of two 
different dominant negative Sox3 to repress organizer markers. One of the 
dominant negative (Sox3N40I) contained a point mutation in the HMG 
domain that prevented the binding to DNA, while the other (Sox3dNLS) 
contained three point mutations, again in the HMG domain, that prevented 
the nuclear localisation of the protein. Both the mutants induced ectopic 
expression of the organizer markers bozozok, squint, goosecoid, chordin 
and no tail. Moreover, microinjection of mut1 did not repress the 
expression of gsc, as it caused phenotypes similar to both UN and GFP 
controls. Therefore, the data obtained indicates that this mutant present a 
loss of the repressor function compared to the wt. 
In the luciferase reporter assay Mut1 caused a two-fold increase of the 
luciferase activity compared to wt Sox3. This could be due to the fact that 
the deletion made in Sox3 did remove a region involved in Sox3 repressor 
function, thus altering the balance between the activation and repression 
function of the protein and causing greater activation of the reporter gene.  
Two hypotheses that would explain why the over-expression of mut1 had 
a milder impact than the wt on the organizer formation are that the 
deletion affected Sox3 DNA binding properties, or that it affected the 
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nuclear localisation of the protein. These hypotheses would also be 
consistent with the activation of the luciferase reporter gene observed 
after over-expression of Mut1. According to the first hypothesis, a 
decrease in the ability of binding DNA would allow a lower amount of the 
over-expressed protein to bind target sequence and activate/repress 
target genes, therefore mitigating the effect of the over-expression. If, on 
the other hand, the second hypothesis was true, than it would mean that 
the amount of protein transported into the nucleus after translation would 
have decreased (but not completely), and for this reason the mutant Sox3 
would have been less efficient in regulating target genes. 
Another hypothesis that would explain the ectopic expression of boz is 
that Mut1 lost the ability to compete with the Wnt effector factors Tcf/Lef 
for binding to β-catenin, and thus it interfered with the Wnt/β-catenin 
signalling pathway (Fig. 4.4). In fact, in order for β-catenin to bind DNA 
and activate target genes, the interaction with Tcf/Lef is required; in 
Xenopus it has been shown that Sox3, as well as other Sox proteins, can 
interfere with this interaction (Zorn et al. 1999; Zorn et al. 1999). This is 
consistent with the observation that several other Sox proteins have been 
shown to be able to interact with β-catenin, sometimes causing repression 
and other times causing activation of target genes (Zorn et al. 1999; Sinner 
et al. 2004). In zebrafish, it has been shown that Sox3 acts as a repressor of 
the Wnt/β-catenin signalling causing the repression of organizer marker 
genes and confining the formation of the organizer at the correct time and 
position (Shih et al. 2010). It is also known that the activation of boz is 
induced by β-catenin (Fig. 4.1 and Fig. 4.4), (Schier and Talbot 2005); 
therefore, it could be possible that the ectopic expression of boz caused by 
the over-expression of Mut1 was due to the fact that the region deleted in 
Mut1 is involved in the ability of Sox3 to interact with β-catenin. The 
reason why Mut1 did not cause ectopic expression of gsc could be because, 
as mentioned above, Sox3 does not repress gsc as directly as it does 
repress boz (Fig. 4.1). This is consistent with the observation that Mut1 did 
not repress gsc expression. 
122 
 
Zebrafish Sox3 (zfSox3) was found to contain two presumptive 
SUMOylation sites (Laghari 2010) located respectively in the positions 
113-123 and 228-238. SUMOylation consists in the covalent or, in some 
cases, non-covalent (Merrill et al. 2010) attachment of a SUMO 
polypeptide to a lysine flanked by specific residues on the target protein 
and it was found to affect different types of proteins, including 
transcription factors. SUMOylation has been shown to regulate the 
transcriptional activity of different transcription factors, including Sox 
proteins (Gill 2005). It is thought that the covalent attachment of SUMO 
polypeptides to zfSox3 modulates the transcriptional repressor and 
activator function of this transcription factor. However, at the present time 
this mechanism is still being studied. The observation that one of the 
presumptive SUMOylation sites, which is located in the position 113-123, 
is completely deleted in Mut1 suggests another hypothesis for the function 
of the deleted region. It is possible that the SUMOylation of this region of 
the protein is involved in the repressor function of Sox3. That would 
explain why the deletion caused the loss-of-function in the organizer 
repression activity and the activation of the luciferase, which could also be 
caused by a loss of repression function. 
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Figure 4.3 Dominant-negative Sox3 constructs induce ectopic 
expression of boz causing the same phenotype as mut1. Shih et al. showed 
that microinjection of dominant-negative forms of sox3 (sox3N40I and 
sox3dNLS) causes ectopic expression of boz (A), (Shih et al. 2010). The same 
phenotype was found to be caused by microinjection of mut1 (B). The 
pictures show different embryos viewed from the animal pole. 
Figure 4.4 One of the hypotheses that would explain ectopic expression 
of boz caused by over-expression of Mut1. Β-catenin binds the DNA 
together with Tcf/Lef to activate boz (A); Sox3 can compete with this 
interaction causing the repression of boz (B). If Mut1 lost the ability of 
interfering with β-catenin-Tcf/Lef interaction, this would explain why boz
was expressed ectopically (C). 
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4.3.2. Mutant 5 
 
Figure 4.5 Schematic representation of sox3 showing the region deleted in Mut5. 
Mutant 5 carried deletion of a region of 16 amino acids located 
approximately in the middle of the protein (A164-M179, Fig. 4.5). The over-
expression of Mut5, as well as Mut6, did not cause repression of boz 
compared to wt Sox3. However, microinjection of mut5, as well as 
microinjections of mut2, mut3 and mut7 seemed not to cause different 
effects on gsc expression compared to the wt. This observation is 
interesting considering that Mut4, which lacks a region located just before 
Mut2, and Mut6, which lacks the region between the deletions made in 
Mut5 and Mut3, and Mut4, did cause significantly milder effects (Fig. 4.6). 
Therefore, the deletion of regions that are next to each other cause 
different effects on the organiser repression function. This proved that the 
deletion strategy developed for the present study is effective to identify 
regions of the protein that have different functions. The reason why Mut5 
did not show the same loss-of-function in the repression of both boz and 
gsc is probably because, as mentioned above, gcs is not only directly 
repressed by Sox3, but also through the repression of boz. 
 
 
 
Figure 4.6 Schematic representation of sox3 showing the positions of the regions deleted in 
Mut2, Mut3, Mut5 and Mut7. 
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Mutant 5 caused a remarkably strong activation of the luciferase 
compared to wt Sox3. Such dramatic effect could be caused by the lack of a 
region that mediates the repressive function of Sox3. This is consistent 
with the findings that Mut5 is unable to repress the expression of bozozok. 
Both experiments support the hypothesis that Mut5 lost the repression 
function of wt Sox3.  
Interestingly, a previous student in the laboratory identified two 
presumptive Groucho binding sites in the sequence of chicken Sox3 
(cSox3) (Laghari 2010). Grouchos are a family of co-repressors that have 
been proven to interact with Tcf, a Sox-like HMG transcription factor 
(Brantjes et al. 2001; Kuo et al. 2013) and it has been suggested that they 
may interact with Sox2 (Liu 2011). The interaction between Tcf and 
Grouchos cause repression of target genes, while the binding with β-
catenin leads to the release of Tcf from Groucho, thus activating the target 
genes (Brantjes et al. 2001; Kuo et al. 2013). It is possible that Grouchos 
interact with Sox3 and regulate the balance between the activator and the 
repressor function of Sox3. The presumptive Groucho binding sites that 
were identified in cSox3 correspond to the amino acids 194-203 and 292-
307. In the zebrafish Sox3 (zfSox3) these regions are conserved and 
corresponding residues are located in the positions 179-188 and 276-291 
(Fig. 3.1). The first of these two presumptive binding sites has been 
deleted in Mut5 and Mut6: Mut5 (A164-M179) was missing the first amino 
acid of the binding site and Mut6 (H180-N200) was missing the rest of the 
site. The second presumptive Groucho binding site was deleted in Mut9 
(Q273-G290) and in Mut10 (V291-I300). 
Therefore, according to this hypothesis, in Mut5 the removal of a region 
involved in the binding of Sox3 with the co-repressor Groucho caused a 
loss of the repressor function and changed the balance between the 
activator and repressor function, causing the failure in the repression of 
boz and the activation of the luciferase reporter. 
Mut2 led to a reduction in the luciferase activity compared to the GFP 
control, where the activity was due only to the endogenous Sox3. This 
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could mean that Mut2 also interfered with the activity of the endogenous 
Sox3. This observation is interesting considering that the deletion of the 
region next to the one deleted in Mut2 caused a totally different effect: the 
dramatic activation showed by Mut5. 
 
4.3.3. Mutant 6 
 
Figure 4.7 Schematic representation of sox3 showing the region deleted in Mut6. 
Mutant 6 lacks of a region of 21 amino acids (H180-N200, Fig. 4.7) which is 
located approximately in the middle of the protein sequence (Fig. 4.7). The 
over-expression of Mut6 did not cause repression of the organizer 
markers compared to wt Sox3 and this could indicate a loss-of-function in 
the repressor activity. These observations are consistent with the 
hypothesis that the removal of a part of a Groucho binding site (179-188) 
changed or prevented the interaction of Mut6 to with Groucho, thus 
leading to the inability of the protein to repress boz and gsc. The fact that 
the phenotypes of the embryos 24 hpf did not differ particularly from the 
embryos microinjected with wt Sox3 is probably due to the functional 
redundancy existing between different SoxB1 factors at later stages of 
development. 
However, Mut6, in contrast to Mut5, did not activate luciferase more than 
wt Sox3. If the above hypothesis that lack of repression is due to loss of 
interaction with Grouchos, then this cannot be the explanation for the 
increased luciferase activity caused by Mut5. Only by analysing interaction 
with Grouchos directly can these possibilities be tested. 
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4.3.4. Mutant 7 
 
Figure 4.8 Schematic representation of sox3 showing the region deleted in Mut7. 
Mutant 7 contained a deletion of 25 amino acids located towards the         
C-terminus of the protein (A226-G250, Fig. 4.8). The over-expression of this 
construct did not show any repressive effect on boz compared to wt sox3. 
However, it seemed to have quite a strong effect on gsc expression, as it 
caused a severe phenotype in almost half of the embryos and a normal 
phenotype in the others, but no mild phenotypes. Moreover, Mut7 
activated the luciferase reporter gene less than the GFP control, in which 
the activation of the reporter is thought to be caused by the endogenous 
Sox3. Therefore, Mut7 seemed to interfere with the transcriptional 
activator function of the endogenous Sox3. These data suggest that the 
deletion made in Mut7 caused a loss of the transcriptional activator 
function of Sox3, and therefore that the deleted region is involved in the 
functioning of Sox3 as activator. 
As mentioned above, zfSox3 was found to contain a presumptive 
SUMOylation site in the position 228-238, which is comprised in the 
deletion made in Mut7. In contrast to what was observed for Mut1, in 
which the other presumptive Sox3 SUMOylation site was deleted, Mut7 
seemed to present a loss of activation function compared to wt Sox3. This 
suggests that SUMOylation of the two different presumptive sites could 
have opposite effects inducing Sox3 to act as a transcriptional repressor 
(site deleted in Mut1) or as activator (site deleted in Mut7). However, it is 
not yet known if SUMOylation occurs at either of these sites.  
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4.3.5. Mutant 10 
 
Figure 4.9 Schematic representation of sox3 showing the region deleted in Mut10. 
Mutant 10 contained a deletion of 10 amino acids located at the very end 
of the C-terminal region of the protein (V291-I300, Fig. 4.9). The over-
expression of mut10 caused a unique phenotype in nearly half of the 
embryos analysed 24 hpf (Fig. 4.8). This phenotype differed from all the 
others found in the same experiment and presented a distribution of ncad 
transcript that resembled the one expected for embryos at approximately 
bud stage (Harrington et al. 2007; Warga and Kane 2007; Dee et al. 2008). 
Normally, at this stage the dorsal epiblast becomes thicker anteriorly and 
forms the neural plate. The neural plate is the earliest recognizable dorsal 
ectodermal primordium of the CNS and forms near the end of gastrulation, 
at about 9-10 hpf. Therefore it seems that the over-expression of Mut10 
affected the development of the CNS in a different way compared to 
wtSox3. Instead of leading to defects that involve duplication or ectopic 
expression of neural tissue, Mut10 seemed to block development at an 
earlier stage, when the first primordium of the nervous system begins to 
form. In particular, it seems possible that embryos injected with Mut10 
presented defects in the extension and conversion cellular movements 
that occur during gastrulation, and therefore retarded their development 
before the completion of gastrulation. This hypothesis is consistent with 
the appearance of these embryos (Fig. 4.10).  
Interestingly, at sphere stage embryos over-expressing mut10 did not 
show any particular difference in the expression of the organizer markers, 
compared to the embryos over-expressing wt sox3. Therefore, it seems 
that the mechanisms that were affected by the deletion and that caused 
the particular phenotype observed 24 hpf are related to processes that 
occur after the sphere stage. 
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The reading of the luciferase activity was lower in embryos over-
expressing Mut10 than embryos over-expressing wt Sox3. This suggests 
that the deletion caused a loss in the transcriptional activator function of 
the protein. 
Together, the data obtained by the analysis of the effects caused by the 
over-expression of Mut10 suggest that this mutant interferes with the 
development of the CNS at a later stage than the sphere stage, presumably 
around the bud stage, and that it lost Sox3 activator function. Therefore, 
the data confirmed the observation that the C-terminal region of Sox3 
contains a trans-activation domain (Bowles et al. 2000; Xia et al. 2000; 
Sutton et al. 2011).  As mentioned in the Introduction (Chapter 1.5.3), Sox3 
acts in Xenopus as a transcriptional activator during the formation of the 
nervous system inducing the neural progenitor markers sox2 and geminin 
(Rogers et al. 2009). It is possible that the deletion made in Mut10 
interfered with the activation of target genes, such as sox2, which are 
normally expressed after the sphere stage in zebrafish and are involved in 
the specification of the neural tissue. 
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Figure 4.10 Microinjection of mut10 caused defects in the development 
of the CNS, which seems not to develop beyond the bud stage. The figure 
shows the expression of ncad in a normal embryo 24 hpf (A), in embryos 24 
hpf injected with mut10 (B, C, D, E) and in a normal embryo at bud stage (F, 
(Dee et al. 2008)). Each picture shows a different embryo viewed from the 
dorsal side. It is clearly visible that the embryos 24 hpf microinjected with 
mut10 presented a phenotype remarkably different to a normal embryo 24 
hpf, but similar to the phenotype of an embryo at bud stage. 
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4.3.6. Mutant 11 
 
Figure 4.11 Schematic representation of sox3 showing the region deleted in Mut11. 
Mutant11 contained a deletion of 11 amino acids that included all the N-
terminal region of the protein, except the initial methionine, but not the 
HMG domain (Fig. 4.11). Interestingly, over-expression of Mut11 did not 
caused the repression of organizer markers compared to wt Sox3. This 
result was unexpected because, while it is thought that the C-terminal 
region of Sox3 contains a trans-activation domain, no particular functions 
have yet been associated with the short N-terminal end of the protein. The 
over-expression of Mut11 induced a fivefold increase in the activity of the 
luciferase and this would suggest that the deleted region is involved in 
Sox3 repressor function. Together these data suggest the hypothesis that 
the short N-terminal region could be involved in Sox3 repressor function. 
Although the HMG domain is clearly involved in DNA binding, there is also 
evidence that it can mediate interactions with other proteins (Harley et al. 
1996; Wilson and Koopman 2002; Zhang et al. 2003). Therefore, another 
hypothesis that would explain the effects caused by the over-expression of 
Mut11 is that the deleted region is normally involved, together with the 
HMG box, in the interaction with a co-repressor. The disruption of such 
interaction would cause the loss of Sox3 repressor function.  
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4.4. Mapping Different Functions of Zebrafish Sox3 
The data obtained with this study allowed drawing a presumptive 
functional map of Sox3 that is represented Table 4.2. 
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Mutant Deletion Function Experiments  Hypotheses  
Mut11 Y2-I13 
Transcriptional 
repression 
• Expression of 
Boz and Gsc 
• Luciferase 
Reporter 
Assay 
• Binding of 
co-
repressors 
together 
with the 
HMG box 
Mut1 
P100-
G123 
Transcriptional 
repression 
• Expression of 
Boz and Gsc 
• Luciferase 
Reporter 
Assay 
• DNA binding 
and/or 
nuclear 
localisation  
• Interaction 
with Wnt/β-
catening 
signalling 
• SUMOylation 
induced 
repressor 
function 
Mut5 
A164-
M179 
Transcriptional 
repression 
• Expression of 
Boz 
• Luciferase 
Reporter 
Assay 
• Binding with 
Groucho  
Mut6 
H180-
N200 
Transcriptional 
repression 
• Expression of 
Boz and Gsc 
 
• Binding with 
Groucho 
Mut7 
A226-
G250 
Transcriptional 
activation 
• Luciferase 
Reporter 
Assay 
• SUMOylation 
induced 
activator 
function 
Mut10 
V291-
I300 
Transcriptional 
activation 
• Luciferase 
Reporter 
Assay 
• Trans-
activation 
Table 4.2 The region deleted in each of the construct was associated with a presumptive function and 
one or more hypothesis that would explain these functions. The first column of the table indicates the 
name of the constructs (Mutant), the second indicates the regions deleted (Deletion), the third the 
presumptive function of Sox3 associated with the deleted region (Function), the fourth the experiments that 
suggested the functions and the last column indicates the hypothesis suggested that would explain the 
presumptive functions. The bar at the left represents the sequence of wt Sox3 (N-terminus upwards and       
C-terminus downwards).  The deletions made in each mutant are indicated with a number that refers to the 
name of the constructs. The regions with presumptive repressor function are represented in red while the 
regions with presumptive activator function are represented in green. 
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4.5. General Discussion and Future Studies 
Currently, the mechanisms involved in the modulation of Sox3 function as 
a transcriptional activator or repressor in early embryogenesis are still to 
be solved. It is certain that the HMG domain is involved in the binding of 
the DNA, but there is no certain evidence about the functions mediated by 
other regions of the protein. The functional screening strategy that was 
designed and developed in this study allowed the identification and 
mapping of large regions that are located outside the HMG box and 
presumably associated with the functioning of Sox3 as an activator or as a 
repressor. The consistency of the data obtained with the observations 
found in the literature is encouraging; therefore this study could be 
continued with the aim of drawing a more complete functional map of 
Sox3. The first step would be the repetition of the experiments in order to 
get a statistical confirmation of the data observed. Moreover, other 
experimental approaches are now being considered in order to meet two 
main objectives: firstly, the validation, or the rejection, of the hypothesis 
presented that would explain the function of the regions identified; 
experiments focused on the study of protein-protein interactions, such as 
the interaction between Sox3 and the co-repressor Groucho, or the 
interaction of Sox3 with β-catenin, are now being designed to meet this 
first objective. Secondly, the aim of further studies will be the 
identification of the specific residues involved in the functions associated 
with the regions identified in this study; for this purpose a point mutation 
approach is being considered.       
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6. Media Recipes  
 
6.1. Buffers for Bacterial Growth 
6.1.1. Mu Broth culture medium 
Bactotryptone 
10g 
Yeast Extract 
5g 
NaCl 
10g 
NaOH (1M) 
2ml 
H2O 
up to 1L 
Total Volume 1L 
6.1.2. Mu Broth Agar culture medium 
Bactotryptone 
10g 
Yeast Extract 
5g 
NaCl 
10g 
NaOH (1M) 
2ml 
agar 
1% 
H2O 
up to 1L 
Total Volume 1L 
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6.2. Buffers for Western Blot 
6.2.1. SDS Running Buffer 
 
Tris 30.3 g 
Glycine 188 g 
10% SDS (in SDW) 10 ml 
SDW up to 1L 
Total Volume 1L 
6.2.2. Transfer Buffer 
 
MeOH 200 ml 
Tris 3.03 
Glycine 14.4 
SDW up to 1L 
Total Volume 1L 
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6.3. Buffers for In Situ Hybridization 
6.3.1. 20XSSC Solution 
NaCl 876 g 
Tri-Sodium Citrate 
dehydrate 441 g 
SDW up to 1L 
Total Volume 1L 
The pH of the solution was adjusted to 7.0. 
All SSC solutions made from 20xSSC also contain 0.1% Tween20. 
 
6.3.2. Hybridization Buffer 
Formamide  250 ml 
20x SSC 125 ml 
tRNA (50 mg/ml) 0.5 ml 
Heparin(100 mg/ml) 25 µl 
Citric Acid (1M) 4.6 ml 
Tween20 (20%) 2.5 ml 
H2O 112.5 ml 
Total Volume 500 ml 
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6.3.3. Prehybridization Buffer 
Before preparing the buffer 50 ml Hybridization Buffer were pre-
cooled at -20˚C, while waiting for tRNA and Heparin to thaw on ice. 
Hybridization Buffer  49.5 ml 
tRNA (50 mg/ml) 0.5 ml 
Heparin (100 mg/ml) 25 µl 
Total Volume 50 ml 
The buffer was stored at -20˚C. 
6.3.4. Maleic Acid Buffer (MAB) 
 
Maleic Acid 0.1 M 
NaCl 0.15 M 
The pH of the solution was adjusted to 7.5 using NaOH. The 
solution was then autoclaved. 
6.3.5. Blocking Buffer 
MAB + Boehringer Blocking ReagentTM 2% w/v, incubated at 80˚C 
overnight. The buffer was stored at -20˚C. 
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6.3.6. BCL Buffer III 
1M Tris-HCl (pH 9.5) 5 ml 
5M NaCl 1 ml 
0.5M MgCl2 5 ml 
Tween20 (20%) 0.25 ml 
SDW up to 50 ml 
Total Volume 50 ml 
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7. Appendix 
7.1. Map of the pβUT2-zfSox3-HA Vector 
 The vector contains Xenopus β-globin 5’-UTR (Hind III – Bgl II blunt) and 
3’-UTR from PSP64T (Bg I – Hind III) at either ends of Bluescribe’s 
polylinker (pβUT1), replaced with Xba-Kpn with synthetic polylinker 
(pβUT2). 
 
 
  
                                 Sox3 (1-900)   
  XbaI                                                                                  Xho I                           Bam HI 
TCT AGA TTA AGA ATG TAT AAC …. ACC CAC ATT TCT CGA GAC GTC GAC GGA TCC  
         HA 
 
CGA TAT CCA TAC GAT GTT CCA GAT TAC GCG TAT CCA TAC GAT GTT CCA GAT TAC  
        
                  Kpn I 
GCG TGA TAG GTA CC 
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7.2. Map of the pCS2nls.GFP Vector 
To create pCS2nlsGFP, an oligomer encoding a nuclear localisation signal 
derived from SV40, a large T antigen was inserted into plasmid pCS*mt-
SGP (Klymkowsky 1996). Oligonucleotide sequences used were:  
• nlsF: aat tcc cca aaa aag aag aga aag gta gaa t 
• nlsR: cta gat tct acc ttt ctc ttc ttt ttt ggg g  
More information on: pCS2*mt-SGP at http://spot.colorado.edu/~klym/  
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7.3. Primers Designed and Used for the Cloning of 
Deletion Mutant Sox3 Constructs 
• Mutant 1 (P100-G123) 
PRIMER N’R: ggc gtg ctc ctt cat gtg cat ggc 
Length=24  Tm= 65˚C  G+C= 63%  
PRIMER C’F: ggc gga ctc ctg gcg ccc ggt 
Length=21  Tm=70˚C G+C=81% 
 
• Mutant 2 (V139-L163) 
PRIMER N’R: ggc cga cac cgc gtt gtt gac agc 
Length=24   Tm=67˚C    G+C=67% 
PRIMER C’F: ggc gcc tac cct caa cat ccc agc 
Length=24    Tm=67˚C    G+C=67% 
 
• Mutant 3 (A201-G221) 
PRIMER N’R: ggc gtt cat gta ggt ctg agc cgt 
Length=24   Tm=64˚C    G+C=58% 
PRIMER C’F: ggc ttg ggc tcc atg gct tcg gtg 
Length=24   Tm=67˚C    G+C=67% 
 
• Mutant 4 (G124-G140) 
PRIMER N’R: ggc ccc tgg caa aga ata ctt gtc 
Length= 24 Tm= 62˚C  G+C= 54%  
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PRIMER C’F: ggc cag cgg atg gac tac acg cac  
Length= 24 Tm=66˚C G+C=67% 
 
 
• Mutant 5 (A164-M179) 
PRIMER N’R: ggc cag ctg gtc ctg cat gag gga  
Length= 24 Tm= 67˚C  G+C= 67%  
PRIMER C’F: ggc cac cgg tac gac atg gcg gga 
Length=24  Tm=69˚C G+C=71% 
 
• Mutant 6 (H180-N200) 
PRIMER N’R: ggc cat ctg ctg gat ctg ggg gct 
Length=24  Tm= 67˚C  G+C= 67%  
PRIMER C’F: ggc gcc gcg tcc acg tac agc agc 
Length=24  Tm=70˚C G+C=75% 
 
• Mutant 7 (A226-G250) 
PRIMER N’R: ggc cat gga gcc caa acc cat   
Length=21  Tm= 63˚C  G+C=63 %  
PRIMER C’F: ggc gac ctg aga gat atg ata agc 
Length=24  Tm=57˚C G+C=50% 
 
• Mutant 8 (D251-G263) 
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PRIMER N’R: ggc tcc caa aca agc acg ctg aga 
Length=24  Tm= 64˚C  G+C= 58%  
PRIMER C’F: ggc gga gac agc gcc gac cac tcc 
Length=24  Tm=70˚C G+C=75% 
 
• Mutant 9 (Q273-G290) 
PRIMER N’R: ggc tag act gga gtg gtc ggc gct 
Length=24  Tm= 67˚C  G+C= 67%  
PRIMER C’F: ggc gtg aac gga acg cta ccc cta 
Length=24  Tm=68˚C G+C=71% 
• Mutant 10 (V291-I300) 
PRIMER N’R: ggc gcc tgt ccc tgc gct ttg ata 
Length=24  Tm= 66˚C  G+C= 63%  
PRIMER C’F: ggc tct  cga gac gtc gac gga tcc 
Length=24  Tm=65˚C G+C=67% 
 
• Mutant 11 (Y2-I13) 
PRIMER N’R: ggc cat tct taa tct aga gtc gat ctg 
Length=27  Tm= 57˚C  G+C= 42%  
PRIMER C’F: ggc ccg cag tcc aac acg g         
Length=19  Tm=65˚C G+C=74% 
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7.4. Map of the Reporter Plasmid Used for the 
Luciferase Reporter Assay 
The basic pGL3 vector was modified by insertion of F1 promoter followed 
by 3 repetitions of Sox3 binding sites and the firefly luciferase gene. The 
plasmid also contains the Ampicillin resistance gene. The insert is shown 
in the next page. 
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Insert of the pGL3-3XSX plasmid as follows: 
 
TGATNTTCAGCATCTTTACTTTCNCCAGCGTTTCTGGGNGAGCAAAANCAGGAANGCAAAATGCCGC
AAAAAAGGGAATNANGGCGNCACGGAAATGTTGAATACTCATACTCTTCNTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAG
GGGTTCCGCGCACATTTCCCCGAAAAGTGCCACNTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGC
GGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTT
TCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGG
GTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTG
GGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCT
TGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGAT
TTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAAC
GCTTACAATTTGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTT
CGCTATTACGCCAGCCCAAGCTACCATGATAAGTAAGTAATATTAAGGTACGTGGAGGTTTTACTTGCT
TTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTG
TTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTT
CACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATGGTACTGTAACTGAGCTAACATA
ACCCGGGAGGTACCGAGCTCTTACGCGTGCTAGCTCGAGATCCGCGCCTTTGTTCTCCCCAGATCCGC 
                     KpnI        SacI         MluI           NheI     XhoI 
GCCTTTGTTCTCCCCAGATCCGCGCCTTTGTTCTCCCCAGATCTACTTGGGCATAAAAGGCAGAGCAGG
GCAGCTGCTGNTAAGCTTGGCATTCCGGTACTGTTGGTAAAGCCACCATGGAAGACGCCAAAAACAT 
               HindIII 
AAAGAAAGGCCCGGCGCCATTCTATCCGCTGGAAGATGGAACCGCTGGAGAGCAACTGCATAAGGCT
ATGAAGAGATACGCCCTGGTTCCTGGAACAATTGCTTTTACAGATGCACATATCGAGGTGGACATCAC
TTACGCTGAGTACTTCGAAATGTCCGTTCGGTTGGCAGAAGCTATGAAACGATATGGGCTGAATACAA
ATCACAGAATCGTCGTATGCAGTGAAAACTCTCTTCAATTCTTTATGCCGGTGTTGGGCGCGTTATTTA
TCGGAGTTGCAGTTGCGCCCGCGAACGACATTTATAATGAACGTGAATTGCTCAACAGTATGGGCATT
TCGCAGCCTACCGTGGTGTTCGTTTCCAAAAAGGGGTTGCAAAAAATTTTGAACGTGCAAAAAAAGCT
CCCAATCATCCAAAAAATTATTATCATGGATTCTAAAACGGATTACCAGGGATTTCAGTCGATGTACAC
GTTCGTCACATCTCATCTACCTCCCGGTTTTAATGAATACGATTTTGTGCCAGAGTCCTTCGATAGGGA
CAAGACAATTGCACTGATCATGAACTCCTCTGGATCTACTGGTCTGCCTAAAGGTGTCGCTCTGCCTCA
TAGAACTGCCTGCGTGAGATTCTCGCATGCCAGAGATCCTATTTTTGGCAATCAAATCATTCCGGATAC
TGCGATTTTAAGTGTTGTTCCATTCCATCACGGTTTTGGAATGTTTACTACACTCGGATATTTGATATGT
GGATTTCGAGTCGTCTTAATGTATAGATTTGAAGAAGAGCTGTTTCTGAGGAGCCTTCAGGATTACAA
GATTCAAAGTGCGCTGCTGGTGCCAACCCTATTCTCCTTCTTCGCCAAAAGCACTCTGATTGACAAATA
CGATTTATCTAATTTACACGAAATTGCTTCTGGTGGCGCTCCCCTCTCTAAGGAAGTCGGGGAAGCGG
TTGCCAAGAGGTTCCATCTGCCAGGTATCAGGCAAGGATATGGGCTCACTGAGACTACATCAGCTATT
CTGATT 
 
Ampicillin resistance 
F1 promoter 
CTTTGTT 3X repeat of Sox3 binding sites 
luciferase- firefly 
 
 
